Abstract
The main objective of this clinical practice guideline is to provide a series of recommendations for healthcare and exercise professionals, such as neurologists, physical therapists, and exercise physiologists, regarding exercise prescription for patients with migraine.
This guideline was developed following the methodology and procedures recommended in the Appraisal of Guidelines for Research and Evaluation (AGREE). The quality of evidence and strength of recommendations were evaluated with the Scottish Intercollegiate Guidelines Network (SIGN). A systematic literature review was performed and an established appraisal process was employed to rate the quality of relevant scientific research (Grading of Recommendations Assessment, Development, and Evaluation methodology).
The evaluation of the current evidence, the elaboration of the grades of recommendation, and their validation show a B grade of recommendation for aerobic exercise, moderate-continuous aerobic exercise, yoga, and exercise and lifestyle recommendations for the improvement of symptoms, disability, and quality of life in patients with migraine. Relaxation techniques, high-intensity interval training, low-intensity continuous aerobic exercise, exercise and relaxation techniques, Tai Chi, and resistance exercise obtained a C grade of recommendation for the improvement of migraine symptoms and disability.
Supplementary Information
The online version contains supplementary material available at 10.1186/s10194-023-01571-8.
Keywords: Migraine disorders, Exercise therapy, Clinical practice guideline, Migraine symptoms, Disability, Quality of life
Introduction
Migraine is the second leading cause of disability in the world after low back pain [1]. It is a neurological condition with a global prevalence of 14.4%, with the peak prevalence and years of life lived with disability occurring between ages 35 and 39 years [2]. The impact generated on the patient’s various social and family dimensions induces a decline in quality of life and a high economic cost due to work absenteeism, a decrease in work efficiency, and increased healthcare costs [1, 3, 4].
Pharmacological interventions are the most common approaches, typically consisting of the use of non-steroidal anti-inflammatory drugs and triptans for acute management [5, 6]. Prophylactic drugs, such as topiramate or valproic acid, are recommended for chronic migraine [5, 6]. Other pharmacological approaches have been developed in recent years, including the human monoclonal antibody erenumab, botulinum toxin, ditans, and gepants, with good results in the reduction of the frequency of migraine and evolution of migraine attacks [7–9]. However, the main problem with these interventions is their concomitant adverse effects, such as the increase in blood pressure with triptans use, the risk of allergic reaction with monoclonal antibodies, the transient development of blepharoptosis and muscle weakness produced by the injection of botulinum toxin, and interaction with other drugs [6–10].
In addition to pharmacological treatment, behavioral change interventions are fundamental in the clinical management of migraine. These treatments include management of stress, sleep, diet, and exercise [11, 12], of which aerobic exercise and yoga modalities are proposed as preventive alternatives for migraine [12]. Exercise prescription for migraine improvement appears to be a safe and effective intervention that could decrease migraine symptoms and disability and increase quality of life. Aerobic exercise has been the most studied modality [13, 14].
Migraine and exercise information disseminated on social networks has increased exponentially in recent years; however, the quality of that information is questionable [15]. Several international scientific societies recommend the practice of exercise as part of the therapeutic approach to migraine. The French Headache Society includes physical exercise as part of the non-pharmacological treatment of migraine headaches [16]; the Danish Headache Society agrees with a similar recommendation and also includes relaxation and postural exercises [17]; and the American Headache Society recommends regular exercise as part of the biobehavioral treatment of migraine management and prevention [18].
The recommendations of the various headache societies for treatments involving exercise for migraine have one characteristic in common: exercise is mentioned in a very general way, and the various exercise modalities that can be used for migraine treatment are not mentioned in depth. Current scientific evidence has not yet determined the adequate exercise prescription parameters for patients with migraine. Also, there are still no clinical practice guidelines on exercise prescription for migraine. Therefore, we consider it necessary to develop a guide to help clinicians who treat headaches so they can make better recommendations or provide a more specific exercise prescription.
The main objective of this clinical practice guideline is to provide a series of recommendations regarding different exercise modalities that could be effective in the treatment of migraine, and other lifestyle recommendations that could increase the efficacy of exercise interventions, for healthcare and exercise professionals, such as neurologists, physical therapists, and exercise physiologists, so as to better treat patients with migraine. For this proposal, we reviewed the current evidence that shows which exercise interventions improve migraine symptoms (intensity, frequency, and duration), disability, and quality of life. Moreover, the intention of this guideline is to provide parameters of exercise prescription for each exercise modality that could be adapted depending on the patient’s characteristics (e.g. migraine frequency, physical condition, and patient’s preferences). It is not a standard of medical care that determines the exercise intervention approach for migraine treatment. Patients’ clinical presentation, experiences, and expectations, as well as clinicians’ experiences and expertise should guide the exercise prescription based on the best recommendations of the current evidence.
Methods
Overall design and organization
Content experts were appointed by the Institute of Neuroscience and Sciences of Movement (INCIMOV) from the La Salle University Center for Advanced Studies (CSEULS) to conduct a systematic review for the development of clinical practice guidelines regarding exercise prescription for patients with migraine. The guideline was reported in accordance with the Reporting Items for Practice Guidelines in Healthcare (RIGHT) statement [19], and the Appraisal of Guidelines, Research and Evaluation (AGREE) checklist [20] was consulted to ensure the quality of the guideline.
Funding and support
The Professional College of Physiotherapists of the Community of Madrid provided funding and support for this clinical practice guideline. This institution did not take part in the development of the recommendations.
Guideline working group
The task force for the Evidence-Based Practice Guidelines for Exercise Prescription in Migraine Patients consisted of 3 groups: an advisory committee and panel, an expert consensus group, and a scientific evidence evaluation group. Task force members came from a wide range of disciplines, including medicine, physiotherapy, physical activity and sport sciences, and psychology. The scientific-technical knowledge and skills of the task force were related to exercise prescription, migraine diagnosis and treatment, evidence-based medicine, and research methodology.
Registration and protocol
The present clinical practice guideline was registered in the Practice guideline REgistration for transPAREncy (PREPARE) with the registration number PREPARE-2023CN046.
Literature search
A systematic review of the evidence regarding exercise efficacy for improving the symptoms, disability, and quality of life in patients with migraine was performed. This review was elaborated in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) checklist [21]. Moreover, this study was previously registered in PROSPERO, an international register for systematic reviews (CRD42022316319).
Search strategy
The search strategy combined medical subject headings (MeSH) and non-MeSH terms and was applied to the following databases without language or time restrictions: MEDLINE (PubMed), Cochrane, EBSCO, Web of Science, and Google Scholar. The most important terms were “Migraine” and “Exercise,” and the last search was conducted in December 2022. Various sub-searches were developed due to the variety of exercise modalities available for the treatment of migraine. The search strategy information is available in the Supporting Information Appendix S1.
Two independent reviewers conducted the search using the same methodology. If any difference emerged during this phase, it was resolved by consensus. Moreover, original articles were manually screened, and the authors were contacted for further information if necessary.
Selection criteria and data extraction
Systematic reviews, randomized controlled trials, quasi-experimental trials, cohort and case–control designs, case series, case reports, and narrative reviews were screened and included in this review. Any form of study that evaluated the effects of exercise on the symptoms, disability, and quality of life of patients with migraine was of relevance for the development of the present clinical practice guidelines.
A specified list of inclusion and exclusion criteria was elaborated for the screening of articles based on the Population, Intervention, Comparator and Outcome (PICO) measure model [22]. The inclusion criteria for the participants in the articles included were patients with episodic or chronic migraine, diagnosed by a physician based on any of the International Classification of Headache Disorders (ICHD) editions [23], and age 18 years or older. The intervention must be or include exercise in any modality (e.g., aerobic, yoga, resistance training), and the comparator could be any other form of evidence-based exercise intervention that has been shown to be effective for migraine, placebo, or waiting list. Finally, the outcome measures included were pain intensity; migraine attack frequency, defined mainly as days with migraine per month; and duration of migraine attacks, evaluated primarily as the number of hours per migraine attack. Disability and quality of life measures were also analyzed.
For the selection criteria and data extraction, 2 independent reviewers examined the title, abstract, and keywords of each article using the inclusion and exclusion criteria. A full-text article review was similarly conducted for the final elaboration of the set of articles included for the clinical practice guideline recommendations. If any difference emerged during this phase, it was resolved by discussion, mediated by a third reviewer [24].
Methodological quality and risk of bias assessment
Two independent reviewers assessed the methodological quality of the studies included in the review. Systematic reviews were evaluated with the Modified Quality Assessment Scales for Systematic Reviews (AMSTAR), developed by Barton et al. [25]. The Physiotherapy Evidence Database (PEDro) scale was used for the assessment of the randomized controlled trials and the quasi-experimental trials [26]. Cohort studies were evaluated with the Newcastle–Ottawa Quality Assessment Scale (NOS) [27]. For the evaluation of the case series studies, we employed the National Institutes of Health (NIH) Study Quality Assessment Tool for Case Series Studies [28]. Finally, we assessed the methodological quality of the narrative reviews with the Scale for the Assessment of Narrative Review Articles (SANRA) [29]. We also assessed the risk of bias in the systematic reviews and randomized controlled trials. The Risk of Bias in Systematic Reviews (ROBIS) tool was used for the evaluation of the systematic reviews, and the Cochrane revised Risk of Bias 2.0 scale (RoB 2.0) was used for the evaluation of the randomized controlled trials and the quasi-experimental studies [30, 31].
The inter-rater reliability between the 2 reviewers was evaluated with κ. This statistic shows a low level of agreement if κ < 0.5; κ of 0.5–0.7 shows a moderate level of agreement; and κ > 0.7 shows a high level of agreement [32]. If any disagreement appeared in the quality assessment score, it was resolved by consensus, mediated by a third independent reviewer.
Level of evidence and grades of recommendation
Once the methodological quality and risk of bias assessments were performed, the Scottish Intercollegiate Guidelines Network (SIGN) was used to evaluate each study’s level of evidence and to determine the recommendation grade for each exercise intervention. This tool was designed for the development of evidence-based clinical guidelines, and it has a series of advantages: the methodological quality of each study determines the level of evidence; guideline developers must consider the generalizability, applicability, and consistency of each intervention; the clinical impact of the evidence creates a clear link between the evidence and the recommendation; and grades of recommendation are based on the strength of the supporting evidence, taking into account its overall level and the considered judgment of the guideline developers [33]. Table 1 shows the criteria for the levels of evidence and grades of recommendation.
Table 1.
Score criteria for SIGN levels of evidence and grades of recommendation
Levels of evidence | Grades of recommendation | ||
---|---|---|---|
1 + + | High-quality meta-analysis, systematic reviews of RCTs or RCTs with very low risk of bias | A | At least one meta-analysis, systematic review or RCT rated as 1 + + and directly applicable to the target population OR |
1 + | Well-conducted meta-analyses, systematic reviews of RCTs or RCTs with low risk of bias | A systematic review of RCTs or a body of evidence consisting principally of studies rated as 1 + directly applicable to the target population and demonstrating overall consistency of results | |
1- | Meta-analyses, systematic reviews or RCTs, or RCTs with high risk of bias | B | A body of evidence including studies rated as 2 + + directly applicable to the target population and demonstrating overall consistency of results OR |
2 + + |
High-quality systematic reviews of case–control or cohort studies or High-quality case–control or cohort studies with a very low risk of confounding, bias or chance and a high probability that the relationship is causal |
Extrapolated evidence from studies rated as 1 + + or 1 + | |
2 + | Well-conducted case–control or cohort studies with a low risk of confounding, bias or chance and a moderate probability that the relationship is causal | C | A body of evidence including studies rated as 2 + directly applicable to the target population and demonstrating overall consistency of results OR |
2- | Case–control or cohort studies with a high risk of confounding, bias or chance and a significant risk that the relationship is not causal | Extrapolated evidence from studies rated as 2 + + | |
3 | Non-analytic studies, e.g., case reports, case series | D | Evidence level 3 or 4 OR |
4 | Expert opinion | Extrapolated evidence from studies rated as 2 + |
For the development of each intervention summary, we introduced “improve” or “decrease” (grade A), “likely to” (grade B), “might” (grade C), or “remotely” (grade D) depending on the grade of recommendation and the sum of studies that support or negate each intervention efficacy based on the various migraine variables (symptoms, disability, and quality of life). For example, if an intervention achieved a B grade of recommendation and 3 or more studies found a positive effect on pain intensity, it “is likely to decrease pain intensity”. However, if this same intervention had only 1 study that found a positive effect on quality of life, it “remotely improve quality of life”.
Patient diagnosis
Subgroups of patients with migraine were established in the present clinical practice guideline to distinguish between episodic and chronic migraine. The ICHD defines chronic migraine as a headache occurring on 15 or more days per month for more than 3 months, which, on at least 8 days per month, has the features of migraine headache [23]. If the headache and migraine features are of lower frequency, it is considered an episodic migraine. This distinction is important, given that studies regarding exercise interventions on patients with migraine could include one or both diagnostics and influence the results obtained.
Exercise modalities
We provided operational definitions for the various exercise modalities and multimodal interventions of this clinical practice guideline. These operational definitions summarize the main characteristics of the various interventions.
For the general exercise recommendations, we focused on the data from the systematic reviews published, and for the specific exercise modalities recommendations we focused on the available RCTs.
Guideline review process and validation
For the evaluation and validation of the guidelines’ content, a panel of experts was organized. This panel, as mentioned in the guideline working group section, consisted of 8 physical therapists, 4 of whom were also physical activity and sports professionals, a physician, and a psychologist, all with extensive clinician and research experience in the treatment of patients with migraine and exercise prescription. Operational definitions of each intervention, methodological quality, risk of bias, level of evidence, recommendation grade, prescription parameters, and intervention summary were shown to the panel of experts in a presentation during a meeting in June 2022. The experts had to validate these various intervention categories. For this validation process, the experts used a 5-point Likert scale: (1) strongly disagree, (2) somewhat disagree, (3) neither agree nor disagree, (4) somewhat agreement, (5) strongly agree. Moreover, they could add any correction or suggestion to the various categories. After some rounds of deliberation, the experts reached a consensus and determined the validity of each modality and category.
Updates
The procedure for updating the clinical practice guidelines will be structured according to the Checklist for the Reporting of Updated Guidelines [34] and by analyzing the amount and relevance of emerging evidence for exercise prescription in patients with migraine.
Results
Study selection
A total of 60 studies were included in the clinical practice guidelines. Our article search strategy and selection process are shown in the flow diagram (Fig. 1). The included studies were 1 umbrella review and meta-meta-analysis [35], 6 systematic reviews and meta-analyses [13, 36–40], 29 randomized controlled trials [41–69], 4 cohorts [70–73], 1 case series [74], and 19 narrative reviews [75–93]. The methodological quality and risk of bias assessment for each study are shown in Tables 2, 3, 4, 5, 6, and 7, and in Figs. 2, 3, and 4. The agreement between the evaluators in the quality assessment of the studies was high in the PEDro (κ = 0.857), RoB 2.0 (κ = 0.708), and NIH (κ = 1.000) scales, and moderate for the NOS (κ = 0.692) and SANRA scales (κ = 0.681).
Fig. 1.
Flow chart of the study selection and inclusion process according to PRISMA
Table 2.
Modified Quality Assessment Scale for Systematic Review with the information regarding each item score and the total score for each systematic review
Studies | La Touche et al., 2020 [40] | Lemmens et al., 2019 [36] | Long et al., 2022 [37] | Luedtke et al., 2016 [38] | Varangot-Reille et al., 2021 [13] | Wu et al., 2022 [39] | |
---|---|---|---|---|---|---|---|
Were the search methods used to find evidence (original research) on the primary question(s) stated? | Explicitly described to allow replication | Yes | Yes | In Part | In Part | In Part | Yes |
Was the search for evidence comprehensive? | Adequate number and range of databases | Yes | In Part | Yes | Yes | Yes | Yes |
Alternative searches | Yes | Yes | No | Yes | Yes | Yes | |
Adequate range of keywords | Yes | Yes | No | Yes | Yes | No | |
Non-English language | Yes | In Part | Yes | In Part | Yes | No | |
Were the criteria for deciding which studies to include in the overview reported? | Explicitly described to allow replication | Yes | Yes | In Part | Yes | Yes | Yes |
Excludes reviews that do not adequately address inclusion and exclusion criteria | Yes | Yes | No | Yes | Yes | In Part | |
Was bias in the selection of articles avoided? | Two independent reviewers | Yes | Yes | Yes | Yes | Yes | No |
Were the criteria used for assessing the quality of included studies reported? | Explicitly described to allow replication | Yes | Yes | In Part | Yes | Yes | Yes |
Were the methods used to combine and/or compare the findings of relevant studies appropriate? | Meta-analysis conducted on only homogenous data or limitations to homogeneity discussed | Yes | Yes | In Part | In Part | Yes | Yes |
Confidence intervals/effect sizes reported where possible | Yes | Yes | Yes | Yes | Yes | Yes | |
Were conclusions made by the author(s) appropriate? | Supported by the meta-analysis or other data analysis findings | Yes | Yes | No | Yes | Yes | Yes |
Conclusions address levels of evidence for each intervention/comparison | Yes | Yes | No | Yes | Yes | Yes | |
Total | 26 | 24 | 12 | 23 | 25 | 19 |
Item 1: Explicitly described to allow replication (ie, 100% confident that you could replicate it). If explained but you can't be 100% confident of replication = in part; Item 2: Adequate number and range of databases (3 = in part, > 3 = yes); Item 3: Alternative searches such as manual searches, Web of Science, reference lists, contact of prominent authors or other sources of information (1 of these = in part, 2 or more = yes); Item 4: Adequate range of keywords (search likely to be sensitive); Item 5: Non-English language papers included in the search. Must explicitly state that no language restrictions were applied, or something of similar meaning to score yes; Item 6: Explicitly described to allow replication (unambiguous). If described but not 100% clear = in part; Item 7: Excludes reviews that do not adequately address inclusion and exclusion criteria. One of inclusion or exclusion = in part, both = yes;Item 8: Two independent reviewers; Item 9: Explicitly described to allow replication. If the described scale is not valid, and/or reliability is not reported, score = in part; Item 10: Meta-analysis conducted on only homogenous data or limitations to homogeneity discussed; Item 11: Confidence intervals/effect sizes reported where possible; Item 12: Supported by the meta-analysis or other data analysis findings (effect sizes, confidence intervals, etc.) in the review. If only significance levels relied upon = in part; Item 13: Conclusions address levels of evidence for each intervention/comparison (eg, level A-D evidence, strong–weak evidence, etc.). Score: No = 0; In part = 1; Yes = 2. Score < 20 = low quality; Score ≥ 20 = high quality
Table 3.
PEDro scale for randomized controlled trials with the information regarding each item score and the total score for each randomized controlled trial
Studies | Random allocation | Concealed allocation | Comparability of groups at baseline | Participant blinding | Therapist blinding | Assessor blinding | Dropouts | Intention-to-treat analysis | Intergroup statistical comparison | Point measures and variability | Total |
---|---|---|---|---|---|---|---|---|---|---|---|
Ahmadi et al., 2015 [41] | Yes | No | Yes | No | No | No | No | No | Yes | Yes | 4 |
Aslani et al., 2021 [42] | Yes | No | Yes | No | No | No | No | No | Yes | Yes | 4 |
Benatto et al., 2022 [43] | Yes | Yes | No | No | No | Yes | Yes | No | Yes | Yes | 6 |
Bond et al., 2018 [44] | Yes | Yes | Yes | No | No | No | No | Yes | Yes | Yes | 6 |
Boroujeni et al., 2015 [45] | Yes | No | No | No | No | No | No | No | Yes | Yes | 3 |
Butt et al., 2022 [46] | No | No | Yes | No | No | No | Yes | Yes | Yes | Yes | 5 |
Darabaneanu et al., 2011 [47] | No | No | Yes | No | No | No | No | No | Yes | Yes | 3 |
Dittrich et al., 2008 [48] | Yes | No | Yes | No | No | No | Yes | Yes | Yes | Yes | 6 |
Hanssen et al., 2017 [50] | Yes | No | No | No | No | No | No | No | Yes | Yes | 3 |
Hanssen et al., 2018 [49] | Yes | No | No | No | No | No | No | No | Yes | Yes | 3 |
John et al., 2007 [51] | Yes | No | Yes | No | No | No | Yes | No | Yes | Yes | 5 |
Kisan et al., 2014 [52] | Yes | Yes | No | No | No | No | No | No | Yes | Yes | 4 |
Köseoglu et al., 2003 [53] | No | No | No | No | No | No | Yes | No | No | Yes | 2 |
Kumar et al., 2020 [54] | Yes | Yes | No | No | No | No | No | Yes | Yes | Yes | 5 |
Lemstra et al., 2002 [55] | Yes | Yes | Yes | No | No | No | Yes | Yes | Yes | Yes | 7 |
Luedtke et al., 2020 [56] | No | No | No | No | No | No | Yes | No | Yes | Yes | 3 |
Matin et al., 2022 [57] | Yes | No | No | No | No | No | Yes | No | Yes | Yes | 4 |
Mehta et al., 2021 [58] | Yes | Yes | Yes | No | No | No | Yes | Yes | Yes | Yes | 7 |
Meyer et al., 2016 [59] | No | No | Yes | No | No | No | No | No | Yes | Yes | 3 |
Minen et al., 2020 [60] | Yes | No | Yes | No | No | No | No | No | Yes | Yes | 4 |
Narin et al., 2003 [61] | No | No | Yes | No | No | No | Yes | Yes | Yes | Yes | 5 |
Oliveira et al., 2017 [62] | Yes | No | Yes | No | No | No | Yes | No | Yes | Yes | 5 |
Oliveira et al., 2019 [63] | Yes | No | Yes | No | No | No | Yes | Yes | Yes | Yes | 6 |
Overath et al., 2014 [64] | No | No | No | Yes | No | No | Yes | No | No | Yes | 3 |
Santiago et al., 2014 [65] | Yes | No | Yes | No | No | No | No | No | Yes | Yes | 4 |
Varkey et al., 2009 [66] | No | No | No | No | No | No | Yes | No | No | Yes | 2 |
Varkey et al., 2011 [67] | Yes | Yes | Yes | No | No | No | No | Yes | Yes | Yes | 6 |
Wells et al., 2021 [68] | Yes | Yes | Yes | Yes | No | Yes | No | Yes | Yes | Yes | 8 |
Xie et al., 2022 [69] | Yes | Yes | Yes | No | No | No | No | Yes | Yes | Yes | 6 |
Item 1: Subjects were randomly allocated to groups (in a crossover study, subjects were randomly allocated in the order in which treatments were received); Item 2: Allocation was concealed; Item 3: The groups were similar at baseline regarding the most important prognostic indicators; Item 4: There was blinding of all subjects; There was blinding of all therapists who administered the therapy; Item 6: There was blinding of all assessors who measured at least one key outcome; Item 7: Measures of at least one key outcome were obtained from more than 85% of the subjects initially allocated to groups; Item 8: All subjects for whom outcome measures were available received the treatment or control condition as allocated, or, where this was not the case, data for at least one key outcome were analyzed by “intention to treat”; Item 9: The results of between-group statistical comparisons are reported for at least one key outcome; Item 10: The study provides both point measures and measures of variability for at least one key outcome; Score: No = 0; Yes = 1. Poor = 0–3 points; Fair = 4–5 points; Good = 6–8 points; Excellent = 9–10 points
Table 4.
NOS scale for cohort studies with the information regarding each item score and the total score for each cohort study
Selection | Comparability | Outcome | Total | Methodological Quality | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Study | Representativeness of the exposed cohort | Selection of the non-exposed cohort | Ascertainment of exposure | Outcome of interest not present at start | Comparability of cohorts on the basis of the design or analysis | Assessment of outcome | Follow-up long enough for outcomes to occur | Adequacy of follow up of cohorts | ||
Gaul et al., 2011 [70] | - | - | ★ | ★ | - | - | ★ | - | 3/9 | Poor |
Hagan et al., 2021 [71] | ★ | ★ | - | ★ | ★★ | - | - | ★ | 6/9 | Good |
Seok et al., 2020 [72] | ★ | ★ | ★ | ★ | ★★ | - | ★ | ★ | 8/9 | Excellent |
Woldeamanuel et al., 2016 [73] | ★ | ★ | - | ★ | ★★ | - | ★ | ★ | 7/9 | Good |
Scores: ★ = 1 score. Poor = 0–3 stars; Fair = 4–5 stars; Good = 6–7 stars; Excellent = 8–9 stars
Table 5.
Item Quality Assessment Tool for Case Series Studies Scale with the information regarding each item score and the total score for the case series study
Study | Was the study question or objective clearly stated? | Was the study population clearly and fully described, including a case definition? | Were the cases consecutive? | Were the subjects comparable? | Was the intervention clearly described? | Were the outcome measures clearly defined, valid, reliable, and implemented consistently across all study participants? | Was the length of follow-up adequate? | Were the statistical methods well described? | Were the results well described? | Total |
---|---|---|---|---|---|---|---|---|---|---|
Elinoff et al., 2019 [74] | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 8 (Excellent) |
Scores: No = 0; Yes = 1. Poor = 0–25%; Fair = 26–50%; Good = 51–75%; Excellent = 76–100%
Table 6.
SANRA scale for narrative reviews with the information regarding each item score and the total score for each
Studies | Justification of the article’s importance for the readership | Statement of concrete aims of formulation of questions | Description of the literature search | Referencing | Scientific reasoning | Appropriate presentation of data | Total |
---|---|---|---|---|---|---|---|
Agbetoy et al., 2022 [93] | 0 | 0 | 1 | 2 | 0 | 0 | 3 |
Ahn et al., 2013 [75] | 0 | 1 | 0 | 2 | 1 | 1 | 5 |
Amin et al., 2018 [76] | 2 | 2 | 1 | 2 | 2 | 2 | 11 |
Barber et al., 2020 [77] | 2 | 2 | 0 | 2 | 2 | 2 | 10 |
Becker et al., 2009 [78] | 0 | 0 | 0 | 0 | 2 | 1 | 3 |
Busch V, Gaul C, Headache, 2008 [80] | 1 | 2 | 1 | 2 | 2 | 2 | 10 |
Busch V, Gaul C, Schmerz, 2008 [79] | 2 | 2 | 2 | 2 | 2 | 2 | 12 |
Daenen et al., 2015 [81] | 1 | 2 | 0 | 2 | 1 | 0 | 6 |
Hindiyeh et al., 2013 [82] | 1 | 1 | 0 | 1 | 1 | 1 | 5 |
Irby et al., 2016 [83] | 2 | 1 | 0 | 2 | 2 | 1 | 8 |
Lippi et al., 2018 [84] | 2 | 2 | 1 | 1 | 0 | 2 | 8 |
Mauskop et al., 2012 [85] | 1 | 1 | 0 | 2 | 1 | 1 | 6 |
Meyer et al., 2018 [86] | 1 | 1 | 0 | 2 | 2 | 2 | 8 |
Guarín-Duque et al., 2021 [87] | 1 | 2 | 1 | 2 | 1 | 0 | 7 |
Patel et al., 2019 [88] | 2 | 2 | 0 | 2 | 2 | 1 | 9 |
Robblee et al., 2019 [89] | 1 | 2 | 0 | 2 | 2 | 1 | 8 |
Song et al., 2021 [90] | 1 | 2 | 1 | 2 | 2 | 2 | 10 |
Tepper et al., 2015 [91] | 1 | 2 | 0 | 1 | 2 | 2 | 8 |
Wells et al., 2019 [92] | 0 | 2 | 1 | 2 | 2 | 2 | 9 |
Score: No = 0; In part = 1; Yes = 2. There are no established cut-offs for different grades of quality
Table 7.
Systematic reviews and meta-analysis risk of bias assessment within studies based on the ROBIS tool
Review | Phase 2 | Phase 3 | |||
---|---|---|---|---|---|
1. Study eligibility criteria | 2. Identification and selection of studies | 3. Data collection and study appraisal | 4. Synthesis and findings | Risk of bias in the review | |
La Touche et al., 2020 [40] |
![]() |
![]() |
![]() |
![]() |
![]() |
Lemmens et al., 2019 [36] |
![]() |
![]() |
![]() |
![]() |
![]() |
Long et al., 2022 [37] |
![]() |
![]() |
![]() |
![]() |
![]() |
Luedtke et al., 2016 [38] |
![]() |
![]() |
![]() |
![]() |
![]() |
Varangot-Reille et al., 2021 [13] |
![]() |
![]() |
![]() |
![]() |
![]() |
Wu et al., 2022 [39] |
![]() |
![]() |
![]() |
![]() |
![]() |
= low risk;
= high risk;
= unclear risk
Fig. 2.
Risk of bias summary of the systematic reviews and meta-analysis included in the study based on the ROBIS results
Fig. 3.
Clinical trial risk of bias assessment within studies based on the RoB 2.0 tool
Fig. 4.
Risk of bias summary of the clinical trials included in the study based on the RoB 2.0 results
Sample characteristics
A total of 2493 patients with migraine were included in the articles that compose this clinical practice guideline, 1692 in the intervention groups and 801 in the control group. From this total sample, 1699 patients presented an episodic migraine diagnosis in 28 studies [41–45, 47–54, 57–59, 61–64, 66–71, 73, 74], and 524 had a chronic migraine diagnosis in 6 studies [44, 55, 65, 70, 72, 73]. However, 270 individuals were included in studies that did not specify the number of episodic and chronic migraine diagnoses [46, 56, 60]. The mean age range of the patients included in the studies was 29 to 51 years, and the mean body mass index range was 22.04 to 35.8 kg/m2. Of the total sample, 2133 were women and 360 were men.
Outcome measures
Migraine frequency was measured by attacks per month or days with migraine per month; pain intensity was evaluated with the Visual Analog Scale (VAS), the Numeric Pain Rating Scale (NPRS), the Numeric Rating Scale (NRS), or other ordinal scales (e.g., 0 = no pain; 1 = mild; 2 = moderate; 3 = severe). Pain duration was registered as average minutes per attack, the average duration of headaches in hours, hours per day, hours per month, duration of headache episodes in days or days with a migraine episode. Disability was evaluated with the Migraine Disability Assessment questionnaire (MIDAS), the Headache Impact Test-6 (HIT-6), and the Headache Disability Index (HDI), and quality of life was measured with the Migraine Specific Quality of Life Questionnaire (MSQoL), the Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQv 2.1), and the Quality of Life Profile for the Chronically Ill (PLC).
Evidence statements and recommendations
Grade B of recommendation
Aerobic exercise
This modality contains general advice for aerobic exercise without a specific definition or accurate exercise prescription parameters.
It obtained a B grade of recommendation based on the results of 1 umbrella review with meta-meta-analysis [35], and 4 systematic reviews with meta-analysis [13, 36, 38, 40] (Table 8). Professionals should consider that prescription of aerobic exercise for patients with migraine is likely to decrease pain frequency, intensity, and duration, and to improve quality of life.
Table 8.
Summary table with each exercise modality and its respective studies
Study | Design and Diagnosis | Intervention | Key Outcomes and Follow-up | Results Within Group | Results Between Group | Level of Evidence | Adverse effects |
---|---|---|---|---|---|---|---|
AEROBIC EXERCISE GRADE OF RECOMMENDATION: B in favour of intervention | |||||||
Herranz-Gómez et al., 2021 [35] |
MMA, umbrella and mapping review ICHD |
Experimental group: Aerobic exercise, manual therapy and manual therapy with therapeutic exercise Control group: Any type of intervention it was possible to isolate |
Frequency (days/month or days/week) Pain intensity (VAS, NPRS, numeric pain index, MVK pain scale) Disability (HDI) Quality of life (HIT-6, SF-36, SF-12) |
There is moderate evidence that aerobic exercise reduces pain intensity in migraine patients. The applied interventions showed a positive effect in terms of pain intensity, quality of life and frequency | 1- | No adverse effects were reported | |
La Touche et al.,2020 [40] |
SR of RCTs and q-RCTs MA of RCTs Migraine with or without aura diagnosed with ICHD |
Experimental group: aerobic exercise Control group: Other forms of exercise, minimal education, information, maintenance of daily living activity or drugs |
Frequency (days/month or days/week) Pain intensity (VAS) Duration (hours of migraine) Quality of life (HIT-6, PLC, WHO-5, MSQoL, grading the severity of chronic pain) |
It was found statistically significant differences in the decrease in pain intensity, frequency and duration of migraine in the short term, and an increase in quality of life. Aerobic exercise has low to moderate evidence in migraine patients | 1- | No adverse effects were reported | |
Lemmens et al., 2019 [36] |
SR of RCTs and q-RCT s MA of RCTs and Q-RCT s Migraine diagnosed with the ICHD-II |
Experimental group: Physical endurance, physical fitness, aerobic exercise and exercise therapy performed during at least 6 weeks Control group: no intervention, education, treatment based on medication, relaxation therapy and advice to maintain habitual daily activity |
Frequency (days/month) Pain intensity (NPRS, VAS) Duration (hours/attack and hours/month) |
Significant reductions in the number of migraine days after aerobic exercise treatment were found, and small to moderate reductions in attack duration and pain intensity after aerobic exercise intervention | 1- | No adverse effects were reported | |
Luedtke et al., 2016 [38] |
SR of RCTs and q-RCT s MA of RCTs Migraine diagnosed with IHS criteria |
Experimental group: standard physiotherapy (exercise, manual therapy, soft-tissue techniques, or strength and endurance training) Control group: placebo, standard care, waiting list or other active intervention |
Frequency (number of episodes or number of headache days within a defined period of time) Pain intensity (VAS) Duration (hours or days without relief) |
Aerobic exercise results suggest a statistically significant reduction in the intensity, frequency and duration of migraine | 1- | No adverse effects were reported | |
Varangot et al., 2021 [13] |
SR and MA of RCTs ICHD and medical diagnosis |
Experimental group: exercise training (aerobic training, strength training, yoga or aerobic and strength training) Control group: non-active interventions, education, relaxation, breathing or no interventions |
Frequency (painful days/month) Pain intensity (VAS, NRS) Duration (hours) Disability (HDI, HIT-6, HIT, PDI) Quality of life (SF-36) |
Aerobic training has a small to moderate clinical effect on pain intensity and frequency of headache episodes in migraine patients, with very low to low certainty of evidence | 1- | The study of Lemstra et al. 2002 reported minor musculoskeletal pain in 20% of patients in the intervention group, which include exercise as part of the therapy | |
Ahn et al., 2013 [75] | Narrative review | There are several lines of evidence supporting the role of exercise in migraine management. Though individually these studies have some limitations, they are still altogether compelling because this view still emerges clearly from several independent lines of investigation | - | 4 | No adverse effects were reported | ||
Amin et al., 2018 [76] |
Narrative review - |
- | - | It seems that although exercise can trigger migraine attacks, regular exercise may have a prophylactic effect on migraine frequency. This is most likely due to an altered migraine-triggering threshold in people who exercise regularly. Frequency and intensity of exercise that is required is unclear | - | 4 | Exercise can minimally trigger migraine |
Barber et al., 2020 [77] | Narrative review | - | - | An aerobic exercise routine alone is sufficient to reduce migraine frequency, intensity, and duration. Higher-intensity training appears to confer more benefits. The addition of exercise to a traditional preventive regimen may provide added benefits. Patients who cannot tolerate high-impact exercise may even benefit from low-impact exercises like yoga | - | 4 | Exercise may induce migraine |
Busch V, Gaul C, Headache, 2008 [80] |
Narrative review - |
- | - | Most of the reviewed studies did not find a significant reduction of headache attacks or headache duration and only indicate a reduction of pain intensity in migraine patients due to regular exercise | - | 4 | It should not be forgotten that exercise can induce sport-related headaches |
Busch V, Gaul C, Schmerz, 2008 [79] |
Narrative review - |
- | - | Regular endurance sports are found in many general recommendations for the treatment of migraine patients. However, the evidence on which these recommendations are based is weak | - | 4 | No adverse effects were reported |
Daenen et al., 2015 [81] |
Narrative review - |
- | - | Aerobic exercise on a submaximal level is the best option in migraine prophylaxis | - | 4 | Exercise could be a migraine-triggering factor |
Guarín-Duque et al., 2021 [87] |
Narrative review - |
- | - | Adults who don't tolerate migraine drugs very well may find relief in preventive therapies such as exercise | - | 4 | Some authors show that exercise, especially if it is at high intensity, can trigger a migraine attack |
Hindiyeh et al., 2013 [82] |
Narrative review - |
- | - |
There are demonstrable differences in the way migraineurs respond to aerobic exercise during their headaches and there is more than a suggestion that migraineurs do, in fact, process the changes brought on by aerobic activity differently than non-migraineurs or migraineurs when they are inter-ictal |
- | 4 | 22% of migraineurs list exercise as a trigger |
Irby et al., 2016 [83] |
Narrative review - |
- | - | Regular aerobic exercise routine is recommended as a means of managing and preventing migraine. Anyway, the optimal parameters of exercise regimens for migraine are still unclear | - | 4 | Physical activity may not play an important role in triggering or exacerbating migraine |
Lippi et al., 2018 [84] |
Narrative review - |
- | - |
High-intensity exercise should be avoided in patients with a history of exercise-provoked migraine Regular moderate aerobic physical exercise (> 40 min, 3 times per week) seems effective to reduce both the severity and frequency of migraine attacks |
- | 4 | Since exercising may sometimes worsen migraine, being engaged in physical exercise during a migraine attack must be established on an individual basis, according to the personal history of exercise-provoked migraine |
Mauskop et al., 2012 [85] |
Narrative review - |
- | - |
Aerobic exercise is proven to be effective in the prevention of migraine headaches |
- | 4 | No adverse effects were reported |
Patel et al., 2019 [88] |
Narrative review - |
- | - |
The overall data are still insufficient to recommend aerobic exercise as a single therapy for migraine prevention because of methodological limitations |
- | 4 | No adverse effects were reported |
Robblee et al., 2019 [89] |
Narrative review - |
- | The best current recommendation for patients with migraine is to engage in graded moderate cardiorespiratory exercise, although any exercise is better than none | - | 4 | No adverse effects were reported | |
Song et al., 2021 [90] |
Narrative review - |
- | - | Regarding efficacy, side effects, and health benefits, aerobic exercise promises to be a good strategy in the preventive treatment of migraine | - | 4 | Exercise can trigger a migraine attack. Pain aggravation by routine physical activity has been reported by approximately 2/3 of individuals with migraine. High-intensity exercise and an insufficient warm-up period can trigger a migraine attack |
Tepper et al., 2015 [91] |
Narrative review - |
- | - | Aerobic exercise combined with behavioural therapy may be useful as a complementary migraine management | - | 4 | No adverse effects were reported |
Wells et al., 2019 [92] | Narrative review | Aerobic exercise | - | Aerobic exercise reduces migraine frequency, pain intensity, duration of migraine, and migraine disability. Also, yoga and tai-chi may be beneficial for migraine patients | - | 4 | Physical exertion can trigger migraines in some patients |
MODERATE-INTENSITY CONTINUOUS AEROBIC EXERCISE GRADE OF RECOMMENDATION: B in favour of intervention | |||||||
Ahmadi et al., 2015 [41] |
RCT ICHD-II Episodic migraine |
Experimental group: Aerobic exercise (n = 15) Control group: Were told not to exercise (n = 14) |
Frequency (attacks/month) Pain intensity (VAS) Duration (average minutes/attack) Post-immediate |
Significant improvement in all outcomes in the experimental group. No significant change in any variable in the control group | No significant difference between groups in any outcome | 1- | No adverse effects were reported |
Oliveira et al., 2017 [62] |
RCT ICHD II Episodic migraine |
Experimental Group: Aerobic exercise (n = 10) Control Group: Waiting list (n = 10) |
Frequency (days with migraine /month) | Significant improvement in the experimental group. No significant change in the control group | Analysis not performed | 1- | No adverse effects were reported |
Oliveira et al., 2019 [63] |
RCT Migraine ICHD-II Episodic migraine |
Migraine aerobic exercise group (n = 13) Migraine waitlist group (n = 12) Control aerobic exercise group (n = 12) Control waiting list group (n = 13) |
Frequency (attacks/month and days with migraine /month) Pain intensity (0 = no pain; 1 = mild; 2 = moderate; 3 = severe) Post-immediate |
Migraine exercise: Significant improvement in attacks/month, days/month. No significant change in pain intensity Migraine waitlist: No significant change in any outcome |
Favours significantly migraine exercise over migraine waitlist in days with migraine No significant change in pain intensity |
1- | No adverse effects were reported |
Hanssen et al., 2017 [50] |
RCT ICHD III-B Episodic migraine |
Experimental group: HIIT group (n = 16) Experimental group: MCT group (n = 16) Control Group: Maintain habitual daily physical activity profile and received additional standard physical activity recommendations (n = 16) |
Frequency (days/month) Post-immediate |
No significant improvement in any group |
Significant difference that favours HIIT versus MCT No significant difference between HIIT-Control and MCT-Control |
1- | No adverse effects were reported |
Hanssen et al., 2018 [49] |
RCT Episodic migraine without aura ICHD-IIIb |
Experimental group 1: HIIT group (n = 15) Experimental group 2: MCT group (n = 15) Control Group: maintain habitual physical activity profile (n = 15) |
Frequency (days/month) Post-immediate |
No significant improvement in any group |
Significant difference that favours HIIT versus MCT No significant difference between HIIT-Control and MCT-Control |
1- | No adverse effects were reported |
Varkey et al., 2011 [67] |
RCT ICHD-II Episodic migraine |
Group 1: Relaxation group. (n = 30) Group 2: Aerobic exercise group. (n = 30) Group 3: Topiramate group (n = 31) |
Frequency (attacks/month and days with migraine / month) Pain intensity (VAS) Quality of life (MSQoL) Post during treatment period Post during last month of treatment Post 3 months Post 6 months |
Post during the treatment period: Significant reduction in attacks/month in all groups No significant changes in other outcomes in any group |
Post during the treatment period: Significant difference between groups in pain intensity favours the topiramate group No significant difference between groups in attacks/month, days with migraine/month |
1- | No adverse effects were reported |
Post during the last month of treatment: Significant reduction in attacks/month in all groups No significant change in other outcomes in any group |
Post during the last month of treatment: No significant difference between groups in any outcome |
||||||
Post 3 months: Significant reduction in attacks/month in all groups No significant change in other outcomes in any group |
Post 3 months: No significant difference between groups in any outcome |
||||||
Post 6 months: Significant reduction in attacks/month in all groups No significant change in other outcomes in any group |
Post 6 months: No significant difference between groups in any outcome |
||||||
Darabaneanu et al., 2011 [47] |
Q-RCT IHS Episodic migraine with or without aura |
Experimental group: Aerobic exercise (n = 8) Control group: No exercise (n = 8) |
Frequency (days with migraine /month) Pain intensity (NPRS) Duration (h/month) Post-immediate Follow-up 8 weeks |
Significant improvement in all outcomes in the experimental group in post-immediate. No significant change in any outcome in the control group in post-immediate |
Significant interaction between exercise group and frequency and an interaction effect between exercise group and intensity of migraine attacks No significant difference in duration |
1- | 1 person was excluded because of pain during exercise and 4 persons because of a lack of motivation to perform the training |
Luedtke et al., 2020 [56] |
Q-RCT ICHD-III Chronic or frequent episodic migraine |
Group 1: Standard physiotherapy (manual therapy mobilization, myofascial treatment, exercise and education) (n = 79) Group 2: Aerobic exercise (n = 24) |
Frequency (days/month) Disability (MIDAS) |
Post-immediate: No significant change in any outcome measure |
Post-immediate: No significant differences in any outcome measure |
1- | 2 patients discontinued the aerobic group because they reported an increase in headache intensity |
Post 4 weeks: No significant change in any outcome measure |
Post 4 weeks: No significant differences in any outcome measure |
||||||
Post 3 months: No significant change in any outcome measure |
Post 3 months: No significant differences in any outcome measure |
||||||
Narin et al., 2003 [61] |
Q-RCT Episodic migraine without aura. IHS |
Experimental group: Moderate aerobic training and medical treatment. (n = 20) Control group: Medical treatment (n = 20) |
Pain frequency (attack/month) Pain intensity (VAS) Duration (hours) Disability (PDI) Post-immediate |
Significant improvements in both groups in frequency and disability | Significant differences in pain relief favour the experimental group | 1- | No adverse effects were reported |
Overath et al., 2014 [64] |
Q-RCT IHS Episodic migraine with or without aura |
Exercise cohort (n = 28) |
Frequency (attacks/month) Frequency (days/month) Post-immediate |
Significant improvements in all outcomes in favour of intervention | - | 1- | No adverse effects were reported |
Varkey et al., 2009 [66] |
Q-RCT ICHD-II Episodic migraine with or without aura |
Aerobic exercise (n = 26) |
Frequency of days (days/month) Frequency of attacks (attacks/month) Intensity (VAS) Quality of life (MSQol) Post-immediate |
Significant improvements in all outcomes in favour of intervention | - | 1- |
One patient reported a migraine attack immediately after training 3 dropouts because of noncompliance with the treatment, and 3 dropouts because of lack of time |
Hagan et al., 2021 [71] | Cohort Episodic migraine. ICHD-III | Exercise cohort (n = 98) |
Headache frequency (headache/month) Intensity (VAS) Duration (hours) Post-immediate |
Moderate-vigorous exercise at least three times per week had fewer headache frequency, though not statistically significant. This association was significantly stronger in those who used prophylactic medication for migraines | - | 2 + | No adverse effects were reported |
YOGA GRADE OF RECOMMENDATION: B in favour of intervention | |||||||
Long et al., 2022 [37] |
SR of MA of RCT ICHD-IIIb |
Experimental group: Yoga Control group: Standard treatment |
Frequency (Attacks/month) Pain intensity (10-point scale) Duration (hours) Disability (MIDAS and HIT-6) |
- | Compared with the control group, yoga therapy could decrease pain intensity, frequency, duration and disability | 1- | No adverse effects were reported |
Wu et al., 2022 [39] |
SR and MA of RCT ICHD III |
Experimental group: Yoga therapy Control group: Standard medical treatment and self-care |
Frequency (headaches days/month, headaches/week) Intensity (VAS or NRS) Duration (hours) Disability (HIT-6 and MIDAS) |
- | Compared with the control group, yoga therapy was associated with substantially reduced headache frequency and HIT-6 score, but revealed no obvious influence on pain intensity | 1- | No adverse effects were reported |
Boroujeni et al., 2015 [45] |
RCT Episodic migraine IHS |
Experimental Group: Yoga and pharmacological intervention (n = 18) Control group: Pharmacological intervention (n = 14) |
Frequency (Headaches/month) Intensity (VAS) Duration (days) Disability (HIT-6) Post-immediate |
Experimental group: Significant improvements in frequency, intensity and disability, but not in duration Control group: No significant improvements |
Significant improvements in intensity, frequency and disability favour the experimental group. No significant differences in duration | 1- | No adverse effects were reported related to yoga |
John et al., 2007 [51] |
RCT Episodic migraine without aura. IHS 2004 |
Experimental group: yoga (n = 36) Control group: self-care (n = 36) |
Frequency (headache days/week) Intensity (NRS and VAS) Duration (hours) Post-immediate |
Experimental group: Significant improvements in frequency, intensity, and duration of attack Control group: Significant increase of symptoms in all outcomes except duration |
Significant improvements in frequency, intensity and duration of pain favours the experimental group | 1- | No adverse effects were reported |
Kisan et al., 2014 [52] |
RCT Episodic migraine ICHD-II |
Experimental group: Yoga and conventional care (n = 30) Control group: Conventional care (n = 30) |
Frequency (Number of headaches/month) Intensity (VAS) Disability (HIT-6) Post-immediate |
Significant improvements in all outcomes in both groups | Significant improvements in all outcomes favour the experimental group in post-immediate follow-up | 1- | No adverse effects were reported |
Kumar et al., 2020 [54] |
RCT Episodic migraine ICHD-III-beta |
Experimental group: Yoga and medical therapy (n = 80) Control group: Medical therapy (n = 80) |
Frequency (headaches days/month) Intensity (VAS) Disability (HIT-6 and MIDAS) Post-immediate (3 months) |
Significant improvement in all outcomes in both groups | Significant improvements in all outcomes favour experimental group in post-immediate follow-up | 1- | 1 patient reported weight gain in the intervention group, due to medication |
Mehta et al., 2021 [58] |
RCT ICHD III Episodic migraine, with or without aura |
Group 1: Physical therapy: PMR exercise, stretching, isometric exercise of neck muscles, and cardiorespiratory endurance training. (n = 20) Group 2: Yoga. (n = 20) Group 3: Standard treatment. (n = 21) |
Frequency (headaches/month) Intensity (VAS) Disability (HIT-6) 1 month since the initiation of the intervention 2 months since the initiation of the intervention 3 months since the initiation of the intervention (post-immediate) |
Frequency: Significant reduction in all groups at 1 month, 2 month and 3 months Intensity: Significant reduction in all groups at 1 month, 2 month and 3 months Disability: Significant reduction in all groups at 2 and 3 months |
Frequency reduced significantly in group 1, compared to yoga and standard treatment. No significant differences in other outcomes were observed | 1- | No adverse effects were reported |
Wells et al., 2021 [68] |
RCT ICHD-II Episodic migraine |
Experimental group: Standardized training in mindfulness/yoga (n = 45) Control group: Headache education group (n = 44) |
Frequency (migraine days/month) Intensity (VAS) Duration (no data) Disability (MIDAS and HIT-6) Quality of life (MSQv 2.1) 4 weeks post-treatment 16 weeks post-treatment 28 weeks post-treatment |
At 4 weeks post-treatment, both groups showed a reduction in frequency At 4, 16 and 28 weeks post-treatment a reduction in disability and an increase in quality of life was observed in the experimental group compared with the baseline No significant changes over time in intensity and duration |
Significant differences favour the experimental group in disability and quality of life at 4, 16 and 28 weeks post-treatment | 1- | No adverse effects were reported due to the intervention |
Barber et al., 2020 [77] | Narrative review | - | - | The addition of exercise to a traditional preventive regimen may provide added benefits. Patients who cannot tolerate high-impact exercise may even benefit from low-impact exercise like yoga | - | 4 | Exercise may induce migraine |
Wells et al., 2019 [92] | Narrative review | - | - | Aerobic exercise reduces migraine frequency, pain intensity, duration of migraine, and migraine disability. Also, yoga and tai-chi may be beneficial for migraine patients | - | 4 | Physical exertion can trigger migraines in some patients |
EXERCISE AND LIFESTYLE RECOMMENDATIONS GRADE OF RECOMMENDATION: B in favour of intervention | |||||||
Lemstra et al., 2002 [55] |
RCT Chronic migraine with or without aura diagnosed with IHS criteria |
Experimental group: exercise therapy, relaxation, stress management, massage therapy and dietary lecture. (n = 44) Control group: waiting list with standard care with patient´s family physician (n = 36) |
Frequency (days/month) Pain intensity (VAS) Duration (hours/month) Quality of life (PDI) Post-immediate 3 months follow up |
The intervention group experienced statistically significant changes in frequency, pain intensity, duration, disability and quality of life at 3 months follow-up, but not in the control group | Significant differences in frequency, intensity, duration and quality of life favour the experimental group | 1- | Eight subjects in the intervention group reported minor musculoskeletal pain |
Bond et al., 2018 [44] |
RCT ICHD-III Episodic and chronic migraine with or without aura |
Experimental group: fat-restricted diet, 250 min/week of home-based exercise and behavioural modification strategies. (n = 54) Control group: Migraine education. (n = 56) |
Frequency (days/month) Pain intensity (NPRS) Duration (hours/attack) Disability (HIT-6) Post-immediate 4 months follow-up |
Significant reduction in all outcomes in the control group, significant reduction in attack duration and disability but no significant change in frequency and pain intensity in the experimental group in post-immediate Significant reduction in all outcomes in the experimental and control groups except for pain intensity in the control group at follow-up |
No significant difference between groups in any outcome at any endpoint assessment | 1- | No adverse effects were reported |
Seok et al., 2006 [72] |
Cohort ICHD II Chronic migraine |
Lifestyle recommendations with exercise cohort (n = 136) |
Frequency (headaches/month) 1-year follow-up |
Regular exercise was significant positive contributor to the reversion of transformed migraine into episodic migraine | - | 2 + | No adverse effects were reported |
Woldeamanuel et al., 2016 [73] |
Cohort ICHD-IIb Chronic and episodic migraine |
Group 1: Episodic migraine. (n = 175) Group 2: Chronic migraine (n = 175) |
Regular lifestyle behaviours of sleep, exercise, mealtime patterns and hydration status | The chronic migraine cohort showed less regular lifestyle behaviours, including exercise habit, than the episodic migraine cohort | - | 2 + | No adverse effects were reported |
Gaul et al., 2011 [70] |
Cohort ICHD-II Episodic and chronic migraine with or without aura |
Muscular progressive relaxation, headache education, aerobic exercise, individual psychology therapy, group behavioural treatment with lifestyle recommendations cohort (n = 210) | Frequency (attacks/month and days with migraine/month) |
There was a reduction of 45% in the number of attacks per month, and a mean reduction of 4 days with migraine per month Significant amount difference in adherence to lifestyle modification recommendations between the patients who showed a reduction of ≥ 50% in headache days per month and the ones who did not fulfil this outcome at the primary endpoint |
- | 2- | No adverse effects were reported |
Agbetou et al., 2022 [93] |
Narrative review Chronic and episodic migraine |
- | - | Lifestyle modifications are essential in reducing the frequency and severity of migraine attacks. Managing obesity, alcohol, and tobacco consumption discontinuation, regular physical activity, sufficient hydration, and a healthy lifestyle are highly accessible and cost-efficient interventions for any patient with migraine | - | 4 | |
RELAXATION TECHNIQUES GRADE OF RECOMMENDATION: C in favour of intervention | |||||||
Meyer et al., 2016 [59] |
RCT Episodic migraine with and without aura. IHS criteria |
Group 1: PMR training in migraine patients (n = 16) Group 2: waiting list for migraine patients (n = 19) Group 3: PMR training in healthy subjects (n = 21) Group 4: Waiting list for healthy subjects (n = 25) |
Frequency (days/month and attacks/month) Post-immediate and follow-up of 3 months |
Significant improvements in frequency in favour of PMR training in migraine group in post-immediate and follow-up | Post-immediate and follow–up: Significant differences in frequency favour the PMR training in migraine group versus the waiting list for migraine patients’ group | 1- | No adverse effects were reported |
Minen et al., 2020 [60] |
RCT Episodic and chronic migraine ICHD-IIIb |
Experimental group: PMR with a smartphone. (n = 77) Control group: only download the smartphone app. (n = 62) |
Frequency (Days/month) Disability (MIDAS) Post-immediate Follow-up 3 months |
There were no significant differences in all outcomes post-immediate and in follow-up | There was a greater no significant decline in disability in favour of the experimental group at post-immediate and follow-up | 1- | No adverse effects were reported |
Varkey et al., 2011 [67] |
RCT ICHD-II Episodic migraine |
Group 1: Relaxation group. (n = 30) Group 2: Aerobic exercise group. (n = 30) Group 3: Topiramate group (n = 31) |
Frequency (attacks/month and days with migraine / month) Pain intensity (VAS) Quality of life (MSQoL) Post during treatment period Post during last month of treatment Post 3 months Post 6 months |
Post during the treatment period: Significant reduction in attacks/month in all groups No significant changes in other outcomes in any group |
Post during the treatment period: Significant difference between groups in pain intensity favours the topiramate group No significant difference between groups in attacks/month, days with migraine/month |
1- | No adverse effects were reported |
Post during the last month of treatment: Significant reduction in attacks/month in all groups No significant change in other outcomes in any group |
Post during the last month of treatment: No significant difference between groups in any outcome |
||||||
Post 3 months: Significant reduction in attacks/month in all groups No significant change in other outcomes in any group |
Post 3 months: No significant difference between groups in any outcome |
||||||
Post 6 months: Significant reduction in attacks/month in all groups No significant change in other outcomes in any group |
Post 6 months: No significant difference between groups in any outcome |
||||||
Meyer et al., 2018 [86] |
Narrative review - |
- | - | PMR is useful in prophylactic migraine therapy and provides indications of a cortical mechanism of action | - | 4 | No adverse effects were reported |
HIGH-INTENSITY AEROBIC INTERVAL TRAINING GRADE OF RECOMMENDATION: C in favour of intervention | |||||||
Hanssen et al., 2017 [50] |
RCT ICHD III-B Episodic migraine |
Experimental group: HIIT group (n = 16) Experimental group: MCT group (n = 16) Control Group: Maintain habitual daily physical activity profile and received additional standard physical activity recommendations (n = 16) |
Frequency (days/month) Post-immediate |
No significant improvement in any group |
Significant difference that favours HIIT versus MCT No significant difference between HIIT-Control and MCT-Control |
1- | No adverse effects were reported |
Hanssen et al., 2018 [49] |
RCT Episodic migraine without aura ICHD-IIIb |
Experimental group 1: HIIT group (n = 15) Experimental group 2: MCT group (n = 15) Control Group: maintain habitual physical activity profile (n = 15) |
Frequency (days/month) Post-immediate |
No significant improvement in all groups |
Significant difference that favours HIIT versus MCT No significant difference between HIIT-Control and MCT-Control |
1- | No adverse effects were reported |
Matin et al., 2022 [57] |
RCT ICHD II Episodic migraine |
Group 1: HIIT (n = 15) Group 2: Supplementation (Magnesium + B12) (n = 15) Group 3: HIIT + Supplementation (n = 15) Group 4: Control group: Migraine cases (n = 15) |
Frequency (days/month) Intensity (10/15 disabling, 5/9 moderate, ¼ mild) Duration of attacks (minutes) Disability (MIDAS) Post-immediate |
Significant improvement in all outcomes in all groups | Significant improvement in all outcomes in favour of HIIT vs control | 1- | No adverse effects were reported |
LOW-INTENSITY AEROBIC EXERCISE GRADE OF RECOMMENDATION: C in favour of intervention | |||||||
Santiago et al., 2014 [65] |
RCT ICHD-II Chronic migraine |
Experimental group: Amitriptyline and aerobic exercise. (n = 30) Control group: Amitriptyline alone. (n = 30) |
Frequency (days/month) Intensity: 1 (mild), 2 (moderate) and 3 (disabling) Duration of headache (hours/day) Post-immediate |
- | Significant improvements-favour the experimental group in frequency, moderate pain intensity and duration | 1- | 6 persons withdrew for non-adherence to the proposed physical treatment |
Köseoglu et al., 2003 [53] |
q-RCT IHS Episodic migraine without aura |
Aerobic exercise (n = 40) |
Frequency (attacks/month) Intensity (a four-degree scale) Duration (hours of attack/month) Post-immediate |
Significant improvements in all outcomes | - | 1- | No adverse effects were reported |
EXERCISE AND RELAXATION TECHNIQUES GRADE OF RECOMMENDATION: C in favour of intervention | |||||||
Dittrich et al., 2008 [48] |
RCT Episodic migraine with and without aura ICHD-I |
Experimental group: Aerobic exercise group and relaxation (n = 15) Control group: information about Physical activity (n = 15) |
Frequency (attacks/month) Pain intensity (slight, moderate, intense, very intense, intolerable) Quality of life (PLC) |
There were no significant differences in any outcome except in pain intensity in favour of the exercise group at post-immediate | There were no significant differences in any outcome at post-immediate | 1- | No adverse effects were reported |
Mehta et al., 2021 [58] |
RCT ICHD III Episodic migraine, with or without aura |
Group 1: Physical therapy: PMR exercise, stretching, isometric exercise of neck muscles, and cardiorespiratory endurance training. (n = 20) Group 2: Yoga. (n = 20) Group 3: Standard treatment. (n = 21) |
Frequency (headaches/month) Intensity (VAS) Disability (HIT-6) 1 month since the initiation of the intervention 2 months since the initiation of the intervention 3 months since the initiation of the intervention (post-immediate) |
Frequency: Significant reduction in all groups at 1 month, 2 month and 3 months Intensity: Significant reduction in all groups at 1 month, 2 month and 3 months Disability: Significant reduction in all groups at 2 and 3 months |
Frequency reduced significantly in group 1, compared to yoga and standard treatment. No significant differences in other outcomes were observed | 1- | No adverse effects were reported |
Butt et al., 2022 [46] |
Q-RCT Episodic and chronic migraine |
Experimental group: supervised exercises protocol, including aerobic exercise and PMR (n = 14) Control group: prophylactic medicines (n = 14) |
Pain Intensity (NPRS) Disability (MIDAS, HIT-6, HDI) Post-immediate |
There were significant differences in all outcomes in both groups at post-immediate | There were significant differences in all outcomes between groups at post-immediate that favour the experimental group | 1- | No adverse effects were reported |
Becker et al., 2009 [78] |
Narrative review - |
Multidisciplinary treatment, not only medication management is needed in migraine patients. Exercise and relaxation techniques are important components of stress and symptomatic management. For migraine, a more substantial relaxation training program might be necessary | - | - | - | 4 | No adverse effects were reported |
NECK STRENGTH EXERCISE GRADE OF RECOMMENDATION: C against the intervention | |||||||
Benatto et al., 2022 [43] |
RCT Episodic migraine ICHD-III |
Experimental group: craniocervical muscle-strengthening exercise (n = 21) Control group: sham ultrasound group (n = 21) |
Frequency (days with headache/month) Intensity (NRS) Disability (MIDAS) Post-immediate 1-month post-intervention 2-month post-intervention 3-month post-intervention |
Only significant difference in the intensity of headache for both groups | No significant differences in any outcome | 1- | No adverse effects were reported |
TAI-CHI GRADE OF RECOMMENDATION: C in favour of intervention | |||||||
Xie et al., 2022 [69] |
RCT ICHD-III Episodic migraine |
Experimental group: Tai Chi (n = 40) Control group: Waiting list (n = 33) |
Frequency (attacks/month and days with migraine/month) Intensity (VAS) Duration (hours/attack) |
Significant reduction in migraine in frequency (both attacks and days with migraine per month) intensity and duration in Tai Chi group at the end of treatment and follow-up Participants in waiting list only found significant reduction in days with migraine at follow-up |
Significant reduction in Tai Chi group compared to control group only in frequency (both attacks and days with migraine per month) at the end of treatment and follow-up No significant differences in intensity or duration |
1- |
Joint pain (33.8%), muscle pain (33.3%), slight sprain (10.2%) and dizziness (5.1%) All participants indicated tolerability of these symptoms. No serious cases appeared |
Wells et al., 2019 [92] | Narrative review | - | - | Aerobic exercise reduces migraine frequency, pain intensity, duration of migraine, and migraine disability. Also, yoga and tai-chi may be beneficial for migraine patients | - | 4 | Physical exertion can trigger migraines in some patients |
RESISTANCE EXERCISE GRADE OF RECOMMENDATION: C in favour of intervention | |||||||
Aslani et al., 2021 [42] |
RCT Episodic migraine ICHD |
Experimental group: Resistance training. (n = 10) Control group: No exercise. (n = 10) |
Frequency (attacks/month) Intensity (VAS) Duration (Days) Quality of life (HIT-6) Post-immediate |
All outcomes improved significantly in the exercise group in the pre-post measures | There were significant differences that favour resistance training in all outcomes | 1- | No adverse effects were reported |
QI-GONG GRADE OF RECOMMENDATION: D in favour of intervention | |||||||
Elinoff et al., 2019 [74] |
Case series ICHD-II Episodic migraine |
Kiko Exercise and its background (n = 13) |
Frequency (attack/month) Intensity (1 to 5 scale) Disability (MIDAS) Post-immediate |
Disability score reduced by 50% in 4/6 patients Intensity did not show improvement Frequency was improved in more than 1 attack in 3/6 patients |
- | 3 | No adverse effects were reported |
Abbreviations: HDI Headache Disability Index, HIIT High-Intensity Interval Training, ICHD International Classification of Headache Disorders, HIT Headache Impact Test, HIT-6 Headache Impact Test-6. HIS International Headache Society, MA Meta-Analysis, MCT Moderate Continuous Training, MIDAS Migraine Disability Assessment questionnaire, MMA Meta-Meta-Analysis, MSQoL Migraine Specific Quality of life Questionnaire, MSQv 2.1 Migraine-Specific Quality of Life Questionnaire version 2.1, MVK pain scale Modified Von Korff pain scale, NPRS Numeric Pain Rating Scale, NRS Numeric Rating Scale, PDI Pain Disability Index, PLC Quality of Life Profile for the Chronically Ill, PMR Progressive Muscle Relaxation, q-RCT Quasi-Randomized Clinical Trial, RCT Randomized Controlled Trial, SF-12 Short Form-12 Health Survey, SF-36 Short Form-36 Health Survey, SR Systematic Review, VAS Visual Analogue Scale, WHO-5 Five Well-Being Index
Moderate-intensity continuous aerobic exercise
This modality is defined as an exercise intervention that uses large muscle groups, with increased breathing and continuously maintaining a heart rate at an intensity from 12–16 on the Borg perceived exertion scale, a 64%-76% estimated maximum heart rate (HRmax), a 40%-59% heart rate reserve (HRR), or a 40%-59% oxygen uptake reserve (VO2R) [95].
It reached a B grade of recommendation based on the results of 6 randomized controlled trials [41, 49, 50, 62, 63, 67], 5 quasi-randomized controlled trials [47, 56, 61, 64, 66], and 1 cohort study [71] (Table 8). A total of 564 participants were included in these studies, of whom 436 were diagnosed with episodic migraine, 103 were not clearly differentiated between episodic or chronic migraine diagnoses, and 25 were healthy controls.
Professionals should consider that moderate-intensity continuous aerobic exercise, from an 8-week onward intervention applied 3 times per week, is likely to improve headache frequency, might improve pain intensity, and remotely improves attack duration, disability and quality of life in patients with episodic migraine (Table 9).
Table 9.
Highlighted phrases to summarize the strength of recommendation for each exercise modality
Intervention | Migraine diagnosis | Effect | Grade of recommendation | Studies | Outcomes | Results |
---|---|---|---|---|---|---|
Moderate-intensity continuous aerobic exercise | Episodic migraine | Moderate-intensity continuous aerobic exercise, from an 8-week onward intervention applied 3 times per week is likely to improve headache frequency, might improve pain intensity, and remotely improve attack duration, disability, and quality of life in patients with episodic migraine | B in favor of intervention |
N = 12 RCTs (n = 6): Hanssen 2018 [49], Varkey 2011 [67], Hanssen 2017 [50], Oliveira 2017 [62], Oliveira 2019 [63] , Ahmadi 2015 [41] q-RCTs (n = 5): Darabaneanu 2011 [47], Luedtke 2020 [56], Varkey 2009 [66], Overath 2014 [64], Narin 2003 [61] Cohort (n = 1): Hagan 2021 [71] |
Frequency (n = 12): Hanssen 2018 [49], Varkey 2011 [67] , Hanssen 2017 [50], Oliveira 2017 [62], Oliveira 2019 [63], Ahmadi 2015[41], Darabaneanu 2011 [47], Varkey 2009[66], Overath 2014 [64], Luedtke 2020 [56], Narin 2003 [61], Hagan 2021 [71] |
Positive effect (n = 8): Varkey 2011 [67], Oliveira 2017 [62], Oliveira 2019 [63], Ahmadi et 2015 [47], Darabaneanu 2011 [47], Varkey 2009 [66], Overath 2014 [64], Narin 2003 [61] Without effect (n = 4): Hanssen 2018 [49], Hanssen 2017 [50], Luedtke 2020 [56], Hagan 2021 [71] |
Pain intensity (n = 7): Oliveira 2019 [63], Ahmadi 2015 [41], Varkey 2011 [67], Darabaneanu 2011 [47], Varkey 2009 [66], Narin 2003 [61], Hagan 2021 [71] |
Positive effect (n = 4): Ahmadi 2015 [41], Darabaneanu 2011 [47], Varkey 2009 [66], Narin 2003 [61] Without effect (n = 3): Oliveira 2019 [63], Varkey 2011 [67], Hagan 2021 [71] |
|||||
Duration (n = 4): Ahmadi 2015 [41], Darabaneanu 2011 [47], Narin 2003 [61], Hagan 2021 [71] |
Positive effect (n = 1): Ahmadi 2015 [41] Without effect (n = 3): Darabaneanu 2011 [47], Narin 2003 [61], Hagan 2021 [71] |
|||||
Disability (n = 2): Luedtke 2020 [56], Narin 2003 [61] |
Positive effect (n = 1): Narin 2003 [61] Without effect (n = 1): Luedtke 2020 [56] |
|||||
Quality of life (n = 3): Varkey 2011 [67], Varkey 2009 [66], Narin 2003 [61] |
Positive effect (n = 1): Varkey 2009 [66] |
|||||
Yoga | Episodic migraine | Yoga, including asanas, breathing and relaxation techniques, and meditation is likely to improve headache frequency and disability and remotely improves pain intensity and attack duration, from a 6-week onward intervention applied 3 times per week in episodic migraine | B in favor of intervention |
N = 8 SR and MA in RCT (n = 2): Wu 2022 [39], Long 2022 [37] RCT (n = 6): Kumar 2020 [54], Kisan 2014 [52], Boroujeni 2015 [45], John 2007 [51], Mehta 2021 [58], Wells 2021 [68] |
Frequency (n = 8): Wu 2022 [39], Kumar 2020 [54], Kisan 2014 [52], Boroujeni 2015 [45], John 2007 [51], Mehta 2021 [58], Wells 2021 [68], Long 2022 [37] | Positive effect (n = 8): Wu 2022 [39], Kumar 2020 [54], Kisan 2014 [52], Boroujeni 2015 [45], John 2007 [51], Mehta 2021 [58], Wells 2021 [68], Long 2022[37] |
Pain intensity (n = 8): Wu 2022 [39], Kumar 2020 [54], Kisan 2014 [52], Boroujeni 2015 [45], John 2007 [51], Mehta 2021 [58], Wells 2021 [68], Long 2022 [37] |
Positive effect (n = 4): Kumar 2020 [54], Kisan 2014 [52], John 2007 [51], Long 2022 [37] Without effect (n = 4): Wu 2022 [39], Mehta 2021 [58], Boroujeni 2015 [45], Wells 2021 [68] |
|||||
Disability (n = 7): Wu 2022 [39], Kumar 2020 [54], Kisan 2014 [52], Boroujeni 2015 [45], Mehta 2021 [58], Wells 2021 [68], Long 2022 [37] | Positive effects (n = 6) Wu 2022 [39], Kumar 2020 [54], Kisan 2014 [52], Boroujeni 2015 [45], Wells 2021 [68], Long 2022 [37] | |||||
Without effects (n = 1): Mehta 2021 [58] | ||||||
Duration (n = 6): Wu 2022, Boroujeni 2015 [45], John 2007 [51], Mehta 2021 [58], Wells 2021 [68], Long 2022 [37] |
Positive effect (n = 3): John 2007 [51], Mehta 2021 [58], Long 2022 [37] Without effect (n = 3): Wu 2022 [39] , Boroujeni 2015 [45], Wells 2021 [68] |
|||||
Exercise and lifestyle recommendations | Episodic and chronic migraine | Exercise prescription and physical activity in conjunction with other lifestyle recommendations is likely to decrease pain frequency, might improve pain intensity and duration, and remotely decrease disability of patients with episodic and chronic migraine after 6 weeks of intervention with 3–5 sessions per week. Moreover, it remotely improve the function and quality of life of patients with chronic migraine | B in favor of intervention |
N = 5 RCT (n = 2): Bond 2018 [44], Lemstra 2002 [55] Cohort (n = 3): Seok 2006 [72], Woldeamanuel 2016 [73] Gaul 2011 [70] |
Frequency (n = 5): Bond 2018 [44], Lemstra 2002 [55], Seok 2006 [72], Woldeamanuel 2016 [73], Gaul 2011 [70] | Positive effect (n = 5): Bond 2018 [44], Lemstra 2002 [55], Seok 2006 [72], Woldeamanuel 2016 [73], Gaul 2011 [70] |
Pain intensity (n = 2): Bond 2018 [44], Lemstra 2002 [55] | Positive effect (n = 2): Bond 2018 [44], Lemstra 2002 [55] | |||||
Duration (n = 2): Bond 2018 [44], Lemstra 2002 [55] | Positive effect (n = 2): Lemstra 2002 [55], Bond 2018 [44] | |||||
Disability (n = 1): Bond 2018 [44] | Positive effect (n = 1): Bond 2018 [44] | |||||
Quality of life (n = 1): Lemstra 2002 [55] | Positive effect (n = 1): Lemstra 2002 [55] | |||||
Relaxation Techniques |
Episodic and chronic migraine |
Relaxation techniques remotely improve headache frequency after at least 6 weeks, from 1 session per week to daily sessions, in patients with episodic but not chronic migraine. It remotely improves pain intensity after 12 weeks of intervention with 3 sessions per week in patients with episodic migraine | C in favor of intervention |
N = 3 RCT (n = 3): Meyer 2016 [59], Minen 2020 [60], Varkey 2011 [67] |
Frequency (n = 3): Meyer 2016 [59], Minen 2020 [60], Varkey 2011 [67] |
Positive effect (n = 2): Meyer 2016 [59], Varkey 2011 [67] Without effect (n = 1): Minen 2020 [60] |
Pain Intensity (n = 1): Varkey 2011 [67] | Positive effect (n = 1): Varkey 2011 [67] | |||||
Disability (n = 1): Minen 2020 [60] | Without effect (n = 1): Minen 2020 [60] | |||||
Quality of life (n = 1): Varkey 2011 [67] | Without effect (n = 1): Varkey 2011 [67] | |||||
High-intensity aerobic interval training | Episodic migraine | High-intensity aerobic interval training might improve the frequency of pain and remotely improve the intensity of pain, duration, and disability after 8 weeks of intervention with 3 sessions per week in patients with episodic migraine | C in favor of intervention |
N = 3 RCT (n = 3): |
Frequency (n = 3): Hanssen 2017 [50], Hanssen 2018 [49], Matin 2022 [57] |
Positive effect (n = 3) |
Intensity of pain (n = 1): Matin 2022 [57] | Positive effect (n = 1) Matin 2022 [57] | |||||
Duration (n = 1): Matin 2022 [57] |
Positive effect (n = 1) Matin 2022 [57] |
|||||
Disability (n = 1): Matin 2022 [57] |
Positive effect (n = 1) Matin 2022 [57] |
|||||
Low-intensity aerobic exercise | Episodic migraine | Low-intensity aerobic exercise remotely improves headache frequency, intensity of pain, and total duration per month of migraine, after 6 weeks of intervention with 3 sessions per week in patients with episodic migraine | C in favor of intervention |
N = 2 RCT: Santiago 2014 [65] q-RCT: Köseoglu [53] |
Frequency, intensity, and duration (n = 2): Köseoglu [53] Santiago 2014 [65] |
Positive effect in all outcomes (n = 2): Köseoglu [53] Santiago 2014 [65] |
Exercise and relaxation techniques |
Episodic and chronic migraine |
Exercise and relaxation techniques might improve pain intensity and remotely improve frequency and disability of patients with episodic and chronic migraine after 6 weeks of intervention with at least 2 days per week of sessions | C in favour of intervention |
N = 3 RCT (n = 2): Dittrich 2008 [48], Mehta 2021 [58] q-RCT (n = 1): Butt 2022 [46] |
Frequency (n = 2): Dittrich 2008 [48], Mehta 2021 [58] |
Positive effect (n = 1): Mehta 2021 [58] Without effect (n = 1): Dittrich 2008 [48] |
Pain intensity (n = 3): Butt 2022 [46], Dittrich 2008 [48], Mehta 2021 [58] | Positive effect (n = 3): Butt 2022 [46], Dittrich 2008 [48], Mehta 2021 [58] | |||||
Disability (n = 2): |
Positive effect (n = 2): Butt 2022 [46], Mehta 2021 [58] | |||||
Quality of life (n = 1): Dittrich 2008 [48] | Without effect (n = 1): Dittrich 2008 [48] | |||||
Neck strength exercise | Episodic migraine | Neck resistance exercise might not improve migraine frequency, pain intensity, or disability of patients with episodic migraine after 8 weeks of intervention with at least 1 supervised session per week and daily home exercises done twice a day | C against the intervention |
N = 1 RCT: Benatto 2022 [43] |
Frequency, intensity, and disability (n = 1): Benatto 2022 [43] |
Without effect in all outcomes (n = 1): Benatto 2022 [43] |
Tai-Chi | Episodic migraine |
Tai Chi remotely improves migraine frequency in episodic migraine patients after 12 weeks of intervention with 5 sessions per week Tai Chi might not improve pain intensity or attack duration in episodic migraine patients |
C in favor of intervention |
N = 1 RCT (n = 1): Xie 2022 [69] |
Frequency (n = 1): Xie 2022 [69] |
Positive effect (n = 1): Xie 2022 [69] |
Pain intensity (n = 1): Xie 2022 [69] |
Without effect (n = 1): Xie 2022 [69] |
|||||
Duration (n = 1): Xie 2022 [69] |
Without effect (n = 1): Xie 2022 [69] |
|||||
Resistance exercise | Episodic migraine | Resistance exercise remotely improves pain frequency, intensity, and quality of life of patients with episodic migraine after 8 weeks of intervention with at least 3 sessions per week | C in favor of intervention |
N = 1 RCT: Aslani 2021 [42] |
Frequency, intensity, and disability (n = 1): Aslani [42] | Positive effect in all outcomes (n = 1): Aslani [42] |
Qi-Gong | Episodic migraine | Qi-Gong remotely improves pain frequency and disability of patients with episodic migraine after 3 months of intervention with daily sessions. It might not improve pain intensity of patients with episodic migraine | D in favor of intervention |
N = 1 Case series: Elinoff 2019 [74] |
Frequency and disability (n = 1): Elinoff 2009 [74] | Positive effects (n = 1): Elinoff 2009 [74] |
Pain intensity (n = 1): Elinoff 2019 [74] | Without effect (n = 1): Elinoff 2019 [74] |
RCT Randomized controlled trial, q-RCT Quasi-randomized controlled trial
Yoga
Yoga is defined as a mind–body intervention that includes 3 components: physical alignment poses (asanas), breathing techniques, and mindfulness exercises (meditations). Its intensity varies from light to vigorous and includes strength, balance, coordination, and flexibility components [96–98].
It obtained a B grade of recommendation based on the results of 2 systematic reviews with meta-analysis [37, 39], and 6 randomized controlled trials [45, 51, 52, 54, 58, 68] (Table 8). A total of 467 patients with episodic migraine were included in these studies.
Professionals should consider that yoga, including asanas, breathing and relaxation techniques, and meditation is likely to improve headache frequency and disability and remotely improves pain intensity and attack duration, from a 6-week onward intervention applied 3 times per week for episodic migraine (Table 9).
Exercise and lifestyle recommendations
This recommendation is defined as the conjunction of interventions directed to implement habits regarding physical activity, mealtimes, sleep, medication consumption and stress management. Some specific recommendations included here are focused to achieve regular exercise, regular sleep hours along the week, keeping consistent meal hours, adequate hydration, relaxation for stress management and avoiding excessive medication intake.
This modality achieved a B grade of recommendation based on the results of 2 randomized controlled trials [44, 55], and 3 cohorts [70, 72, 73] (Table 8). A total of 954 individuals participated in these studies, divided in 490 episodic and 464 chronic migraine patients.
Professionals should consider that exercise prescription and physical activity in conjunction with other lifestyle recommendations is likely to decrease pain frequency, might improve pain intensity and attack duration, and remotely decrease the disability of both episodic and chronic migraine patients after 6 weeks of intervention with 3–5 sessions per week. Moreover, it remotely improves the function and quality of life of patients with chronic migraine (Table 9).
Grade C of Recommendation
Relaxation techniques
These are defined as techniques commonly employed for headache treatment that include progressive muscle relaxation to help patients identify and discriminate between tense and relaxed muscle groups, autogenic training or cued relaxation, visualization and guided imagery, diaphragmatic breathing, and mini-relaxation, which focuses on a limited number of muscles in the head, neck, and shoulders [99].
This modality reached a C grade of recommendation based on the results of 3 randomized controlled trials [59, 60, 67] (Table 8). A total of 311 individuals participated in these studies, of whom 126 had episodic migraine, 139 had no clear differential diagnosis between episodic or chronic migraine, and 46 were healthy controls.
Professionals should consider that relaxation techniques remotely improve headache frequency after at least 6 weeks, from 1 session per week to daily sessions, in patients with episodic migraine. It remotely improves pain intensity after 12 weeks of intervention with 3 sessions per week in patients with episodic migraine (Table 9).
High-intensity interval training
This modality is defined as exercise that involves alternating periods of high-intensity aerobic exercise at or below maximal oxygen uptake with light recovery exercise or no exercise between intervals [100].
It obtained a C grade of recommendation based on the results of 3 randomized controlled trials [49, 50, 57] (Table 8). A total of 133 patients with episodic migraine were included in these studies.
Professionals should consider that high-intensity aerobic interval training might improve the frequency of pain and remotely improve the intensity of pain, attack duration, and disability after 8 weeks of intervention with 3 sessions per week in patients with episodic migraine (Table 9).
Low-intensity continuous aerobic exercise
The definition of this modality is any activity that uses large muscle groups, increases breathing and heart rate, and can be maintained continuously and rhythmically, using aerobic metabolism to extract energy, at an intensity from 8–11 on the Borg perceived exertion scale, 50%-63% HRmax, 20%-39% HRR, or 20%-39% VO2R [95].
This modality achieved a C grade of recommendation based on the results of 1 randomized controlled trial [65], and 1 quasi-randomized trial [53] (Table 8). A total of 40 episodic and 60 chronic migraine patients participated in these studies.
Professionals should consider that low-intensity aerobic exercise remotely improves headache frequency, pain intensity, and total duration per month of migraine after 6 weeks of intervention with 3 sessions per week in patients with episodic migraine (Table 9).
Exercise and relaxation techniques
This modality consists of the combination of exercise and relaxation techniques, previously defined.
This combination of techniques reached a C grade of recommendation based on the results of 2 randomized controlled trials [48, 58], and 1 quasi-randomized trial [46] (Table 8). A total of 119 patients with migraine were included in these studies, of whom 91 were patients with episodic migraine and 28 had no clear differential diagnosis between episodic or chronic migraine.
Professionals should consider that exercise and relaxation techniques might improve pain intensity and remotely improve the frequency and disability of episodic and chronic migraine patients after 6 weeks of intervention with at least 2 days per week of sessions (Table 9).
Neck strength exercise
This exercise modality consists of motor control and resistance exercise directed to the deep and superficial muscles of the neck and craniocervical regions with the aim of gaining strength.
This modality achieved a C grade of recommendation against this intervention based on the results of 1 randomized controlled trial [43] (Table 8). This study included a total of 42 patients with episodic migraine.
Professionals should consider that neck resistance exercise might not improve migraine frequency, pain intensity, or disability of patients with episodic migraine after 8 weeks of intervention with at least 1 supervised session per week and daily home exercises performed twice a day (Table 9).
Tai chi
Tai Chi is considered a balance training program that contains slow movements that stress postural control, can be performed in groups and requires the person to move body parts gently and slowly while breathing deeply [101].
This modality obtained a C grade of recommendation based on the results of 1 randomized controlled trial [69], and 1 narrative review [92] (Table 8). The randomized controlled trial included a total of 73 patients with episodic migraine.
Professionals should consider that Tai Chi remotely improves migraine frequency in episodic migraine patients after 12 weeks of intervention with 5 sessions per week. It might not improve pain intensity or attack duration (Table 9).
Resistance exercise
Resistance exercise is defined as an exercise modality that provokes an improvement in functional performance by increasing muscular strength, power, speed, hypertrophy, local muscular resistance, motor performance, balance, and coordination [102].
It obtained a C grade of recommendation based on the results of 1 randomized controlled trial [42] (Table 8). A total of 20 patients with episodic migraine participated in this study.
Professionals should consider that resistance exercise remotely improves pain frequency and intensity and disability of patients with episodic migraine after 8 weeks of intervention with at least 3 sessions per week (Table 9).
Grade D of recommendation
Qi-Gong
Qi-Gong is a series of exercises that incorporates elements of slow, gentle movement, and awareness and regulation of breathing, as well as the intentional direction of thoughts, attention, imagery, and sensation [103].
This modality achieved a D grade of recommendation based on the results of a case series study [74] (Table 8). Only 6 patients with episodic migraine were analyzed in this study.
Professionals should consider that Qi-Gong remotely improves pain frequency and disability of patients with episodic migraine after 3 months of intervention with daily sessions. It might not improve the pain intensity of patients with episodic migraine (Table 9).
Prescription exercise parameters
The prescription parameters used in each study are included in Table 10. The summary of the prescription parameters recommended for prescribing each exercise modality in patients with migraine is shown in Table 11.
Table 10.
Prescription parameters used in each of the included studies for each exercise modality
Type of intervention | Trial | Design | Group | Distribution | Frequency | Duration | Intensity | Exercise testing |
---|---|---|---|---|---|---|---|---|
Moderate intensity continuous aerobic exercise | Ahmadi et al. 2015 [41] | RCT | Exercise Group |
Supervised/Unsupervised: No info Warm-up = 15 min Main training = 20 min Cool down = 5 min Training material = No info |
3 times/week for 8 weeks | Total duration = 40 min |
Warm up = Gradual increase in intensity between 11–13 Borg Main training = Gradual increase in intensity between 14–16 Borg Cool down = Borg 11–13 |
- |
Oliveira et al. 2017 [62] | RCT | Exercise group |
Supervised exercise Warm-up = 5 min walking on a treadmill Main training = 30 min walking on a treadmill Cool-down = 5 min walking on a treadmill |
3 times/week for 12 weeks | Total duration = 40 min | Main training = intensity corresponding to the participant’s ventilatory threshold |
-VO2 max -Ventilatory threshold |
|
Oliveira et al. 2019 [63] | RCT | Exercise group |
Supervised exercise Warm-up = 5 min walking/jogging on a treadmill Main training = 30 min walking/jogging on a treadmill Cool-down = 5 min walking/jogging on a treadmill |
3 times /week for 12 weeks | Total duration = 40 min | Main training = speed (m/min), HR, and self-perceived effort corresponding to the participant’s ventilatory threshold |
- VO2 max -Ventilatory threshold |
|
Hanssen et al. 2017 [50] | RCT | MCT |
Supervised exercise Warm-up = 400 m easy running on a treadmill and 2 skipping exercises Main training = Continuous running on a treadmill Cool down = 400 m easy running on a treadmill and stretching exercises |
2 times/week for 12 weeks | Main training = 45 min | Main training = 70% HRmax (± 5 bpm) |
-Individual anaerobic lactate-threshold -HRmax - VO2 max (supervised) |
|
Hanssen et al. 2018 [49] | RCT | MCT |
Supervised exercise Warm-up = 400 m easy running on a treadmill and 2 skipping exercises Main training = Continuous running on a treadmill Cool down = 400 m easy running on a treadmill and stretching exercises |
2 times/week for 12 weeks | Main training = 45 min | Main training = 70% HRmax (± 5 bpm) |
-Individual anaerobic lactate-threshold -HRmax - VO2 max (supervised) |
|
Varkey et al. 2011 [67] | RCT | Exercise group |
Supervised exercise Exercise (15 min warm-up, 20 min exercise and 5 min cool-down) |
3 times/week for 12 weeks | Total duration = 40 min |
Exercise group intensity based on a Borg’s scale of Rated Perceived Exertion (6–20) -Warm up: 11–13 -Exercise: 14–16 -Cool-down: 11–13 |
||
Darabaneanu et al. 2011 [47] | q-RCT | Exercise group |
Supervised exercise Warm-up = 10 min on a treadmill Main training = Jogging on a treadmill Cool down = 10 min on a treadmill |
3 times/week for 10 weeks |
Main training jogging duration of 14th-30th session: 30 min continuously Main training jogging-walking intervals duration from 1st to 13th session (min): 1–2, 2–2, 2–1, 3–1, 3–1, 4–1, 4–1, 5–1, 7–1, 7–1, 10–1, 10–1, 10–1 |
- | - | |
Luedtke et al. 2020 [56] | q-RCT | Supervised Aerobic Exercise Group |
Warm-up = 5–10 min Main training = 30 min aerobic exercise Cool-down = 5–10 min Supervised aerobic exercise modalities = cycling ergometer, treadmill, or cross-trainer Unsupervised aerobic exercise modalities = nordic walking, slow running, outdoor cycling, swimming, cycling ergometer, other activities |
2 times/week for 5 weeks 1st session/week supervised 2nd session/week unsupervised |
Total duration = 40–50 min |
Main training for non-trained patients:11–13 Borg Main training for trained patients:14–15 Borg |
- | |
Narin et al. 2003 [61] | q-RCT | Exercise group |
Supervised exercise 5 min warm-up, 10 min cycling, 10 min walking on a treadmill, 5 min stepper, 10 min training upper extremities at the power station, 10 repetitions of neck and postural exercises, 10 repetitions of rowing and 5 min of cool-down |
3 times/week for 8 weeks | Total duration = 60 min | |||
Overath et al. 2014 [64] | q-RCT | Exercise group (no control group) |
Supervised exercise Warm up = 5–10 min walking Main training = 30 min walking or jogging Cool-down = 5–10 min walking and stretching |
3 times/week for 10 weeks |
Main training jogging duration of 6th-10th session: 30 min continuously Main training jogging-walking intervals duration from 1st to 5th session (min): Steady increase in running time compared to walking time through weeks |
- | - | |
Varkey et al. 2009 [66] | q-RCT | Exercise group (no control group |
Supervised exercise Warm up = 15 min indoor cycling Main training = 20 min indoor cycling Cool-down = 5 min indoor cycling |
3 times/week for 12 weeks | Total duration = 40 min |
Warm up = 11–13 Borg Main training = 14–16 Borg Cool-down = 11–13 Borg |
- | |
Hagan et al. 2021 [71] | Cohort | Exercise | Unsupervised exercise | 0, 1–2, 3–4 or 5 times/week | - |
Light: normal walking, walking downstairs, yoga, gardening, etc Moderate: brisk walking, lawn mowing, shoveling, dancing, etc Vigorous: jogging, running, cycling fast, kickboxing, etc |
- | |
Yoga | Boroujeni et al. 2015 [45] | RCT | Yoga |
Supervised exercise -Eye-related exercises -Backward bending exercises -Fist pavanmoktasana -Second pavanmoktasana -Third pavanmoktasana -Pre-pranayama yoga -Standing-sitting and lying out screw position -Neti exercises -Shavasanas or relaxation Training modality: No info |
3 times/week for 12 weeks | Total duration = 75 min | - | - |
John et al. 2007 [51] | RCT | Yoga |
Supervised exercise -Yoga postures = Stretching of neck, shoulder, back muscles followed by relaxation, toning, strengthening, and flexibility -Breathing and Pranayama -Kriya = Jalaneti (nasal water cleansing) followed by Kapalbhanti (forced exhalations) |
5 times/week for 12 weeks | Total duration = 60 min | - | - | |
Kisan et al. 2014 [52] | RCT | Yoga + conventional care |
Supervised exercise -Relaxation exercises -Breathing exercises -Asanas/posture with awareness -Shavasana Training modality: No info |
5 times/week for 6 weeks | Total duration = 60 min | - | - | |
Kumar et al. 2020 [54] | RCT | Yoga + medical treatment |
Supervised exercise -Prayer = 1 min -Breathing exercises = 8 min -Instant relaxation technique = 1 min -Sukshma vyayama = 15 min -Surya namaskar = 3 min -Quick relaxation technique = 3 min -Asanas = 8 min -Savana-yoga = 10 min -Pranayama = 15 min Training modality: No info |
3 times/ week for 4 weeks | Total duration = 60 min | - | - | |
Mehta et al. 2021 [58] | RCT |
Yoga + Standard Drug Therapy |
Supervised exercise Pranayama, Asana and Savasana Training material: No info |
Daily for 3 months | Total duration = 40 min | - | - | |
Wells et al. 2021 [68] | RCT | Mindfulness-based stress reduction (standardized training in mindfulness/yoga) | Electronic audio files for home mindfulness/yoga practice | 2 h/week for 8 weeks with optional retreat day | Total duration = 30 min | - | - | |
Exercise and lifestyle recommendations | Bond et al. 2018 [44] | RCT | Behavioral weight loss |
Unsupervised Home-based exercise |
5 days/week for 16 weeks | Total duration = Gradually progressed to 50 min of home-based exercise/session | - | - |
Lemstra et al. 2002 [55] | RCT | Exercise group |
Supervised exercise 18 group sessions of aerobic training, strength training, massage, stress management and dietary lecture (relaxation and behavioural therapy) Training modality: No info |
6 weeks with 3 months follow-up | - | - | - | |
Gaul et al. 2011 [70] | Cohort | Muscular progressive relaxation, aerobic exercise and lifestyle recommendation |
Supervised exercise -Headache education = 60 min -Behavioural group session = 90 min -Relaxation training = 60 min -Physical therapy = 60 min -Aerobic ergometer training = 60 min |
Sessions applied 5 days/week minimum | Total duration of programme = 5 h and 30 min | - | - | |
Seok et al. 2006 [72] | Cohort | Lifestyle behaviour modifications, exercise and medication use |
Unsupervised exercise Maintaining regular exercise Training modality: No info |
Session applied at least 3 times/week minimum | Total duration = 30 min minimum per session | - | - | |
Woldeamanuel et al. 2016 [73] | Cohort | Regular Lifestyle Behaviours cohort |
Unsupervised exercise Maintain daily aerobic exercise of any form |
Session applied at least 6 months Minimum |
Total duration = 20 min minimum | Exercise that raises heart rate | - | |
Relaxation techniques | Meyer et al. 2016 [59] | RCT |
Progressive Muscle Relaxation |
Supervised exercise 16 muscle groups that were slightly tensed and thereafter relaxed Training modality: No info |
1 time per week for 6 weeks | - | - | - |
Minen et al. 2020 [60] | RCT |
Progressive Muscle Relaxation |
Unsupervised exercise Smartphone app with Progressive Muscle Relaxation program = 15 min Training modality: No info |
2–4 times per week, for 6 weeks with a follow-up of 3 months | Total duration = 15 min | - | - | |
Varkey et al. 2011 [67] | RCT | Relaxation group |
Unsupervised relaxation Relaxation (6 relaxation exercises, each exercise 5–20 min) |
Daily | Total duration: 30–120 min | - | - | |
High-Intensity aerobic Interval Training | Hanssen et al. 2017 [50] | RCT | HIIT |
Supervised exercise Warm-up = 400 m easy running on a treadmill and 2 skipping exercises Main training = High-intensity interval running on a treadmill Cool down = 400 m easy running on a treadmill and stretching exercises |
2 times/week for 12 weeks |
High-intensity intervals vs active rest period (min) = 4–3 High-intensity intervals were repeated 4 times, with a total duration of 16 min of high-intensity |
High-intensity intervals = 90–95% HRmax (± 5 bpm) reached after 1 min from the beginning of the high-intensity interval Active rest intervals = 70% HRmax |
-Individual anaerobic lactate-threshold -HRmax -VO2 max (supervised) |
Hanssen et al. 2018 [49] | RCT | HIIT |
Supervised exercise Warm-up = 400 m easy running on a treadmill and 2 skipping exercises Main training = High-intensity interval running on a treadmill Cool down = 400 m easy running on a treadmill and stretching exercises |
2 times/week for 12 weeks |
High-intensity intervals vs active rest period (min) = 4–3 High-intensity intervals were repeated 4 times, with a total duration of 16 min of high-intensity |
High-intensity intervals = 90–95% HRmax (± 5 bpm) reached after 1 min from the beginning of the high-intensity interval Active rest intervals = 70% HRmax |
-Individual anaerobic lactate-threshold -HRmax -VO2 max (supervised) |
|
Matin et al. 2022 [57] | RCT | High-Intensity Interval Aerobic Exercise, B12 and Magnesium Supplementation Group |
Supervised exercise Warm-up = 10 min Main training Cool down = 10 min Training modality: Possibly outdoor and indoor cycling |
3 times/week for 8 weeks |
Main training from 1st to 8th wk (min): 10, 15, 20, 25, 30, 35, 40, 40 High-intensity interval duration: No info Low-intensity interval duration: No info |
High-intensity interval Borg’s rating from 1st to 8th wk: 11, 12, 14, 15, 16, 17, 18, 18 High-intensity interval % VO2 max from 1st to 8th wk: 60, 60, 60–65, 65–70, 70–75, 70–75, 75–80, 80 Low-intensity intervals: No info |
-VO2 max | |
Low-intensity aerobic exercise | Santiago et al. 2014 [65] | RCT | Amitriptyline and Aerobic Exercise Group |
Unsupervised exercise Warm-up exercises Main training = Fast walking outdoors |
3 times/week for 12 weeks | Total duration = 40 min | - | - |
Köseoglu et al. 2003 [53] | q-RCT | Exercise group (no control group) |
Unsupervised exercise Warm up = 10 min Main training = 20 min aerobic exercise Resting period = 10 min Training material = No info |
3 times/week for 6 weeks | Total duration = 40 min | Main training = 60% HRmax | HRmax | |
Exercise and relaxation techniques | Butt et al. 2022 [46] | RCT | Moderate Intensity Continuous Aerobic Exercise and Progressive Muscle Relaxation Group |
Supervised exercise Warm-up = 10 min stationary cycling Aerobic exercise main training = 30 min stationary cycling Cool down = 5 min stationary cycling Progressive muscle relaxation = 15 min |
3 times/week for 6 weeks | Total duration = 60 min | - | - |
Dittrich et al. 2008 [48] | RCT | Exercise group |
No information of supervision -Warm-up = 5 min -Aerobic exercise including training of coordination = 15–25 min -Strength training = 10–20 min -Stretching = 5 min -Progressive muscle relaxation = 15 min |
2 times/week for 6 weeks | Total duration = 60 min | - | - | |
Mehta et al. 2021 [58] | RCT |
Physiotherapy and Standard Drug Therapy (Relaxation and exercise) |
Supervised exercise Progressive muscle relaxation exercise, self-stretching of neck muscles (30 s hold 3 repetitions), isometric exercise of neck muscles (5 s hold; 10 repetitions) and cardiorespiratory endurance training (30 min walking) Training material: No info |
Daily for 3 months | Total duration = 40 min | - | - | |
Neck strength exercise | Bennato et al. 2022 [43] | RCT | Neck strength exercise |
First 6 weeks: 2 sets of 10 repetitions with 10 s of endurance for the deep cervical flexor and extensor muscles. Progression in series, repetitions and endurance was based on absence of complaint or pain, and/or execution of movement without compensation in each volunteer Last 2 weeks: add to the previous exercise 3 sets of 15 repetitions for flexor and extensor superficial cervical muscle |
2 sessions/day for 8 weeks Supervised by a physiotherapist once a week for 20 min in an individual session. The rest of the program was done at home |
- | - | - |
Tai Chi | Xie et al. 2022 [69] | RCT | Exercise group |
3 times/week supervised, and 2 times/week unsupervised Warm-up with stretching = 10 min Main training = 45 min. In the first 15 supervised lessons (first 5 weeks), participants learned individual parts of the Modified 33-short form Yang-style Tai Chi Chuan. From the 16th session, participants performed the whole exercise program 3 times per session (15 min each) Cool down with stretching = 5 min Training material = Not needed |
5 times/week for 12 weeks Participants in Tai Chi group kept at least 1 session/week in the following 12 weeks after the end of treatment |
Total duration = 60 min | - | - |
Resistance exercise | Aslani et al. 2021 [42] | RCT |
Resistance Training |
Supervised exercise Warm up = 5 min jogging, 5 min stretching and 5 min weightlifting Main training = 2–3 sets of 8–15 repetitions of arm pull down, arm pull over, sit up, leg extension, leg curl Cool down = 5 min active cooling and stretching movements Training modality: No info |
3 times/week for 8 weeks | Total duration = 30–45 min | Main training performed from 45% RM to 75% RM gradually progressed through the 8 weeks | RM |
Qi-gong | Elinoff et al. 2019 [74] | Case series | Qigong Exercise |
Supervised exercise -First face-to-face exercise sequence = Ju Fu (Gentle Wind) -Qigong exercise DVD duplicating the content of the first and subsequent lessons for home practice = 10 min minimally -Two subsequent face-to-face sessions to reinforce training and add complexity and length to the Kiko sequence |
-Daily home practice -Two subsequent face-to-face sessions every 30 days |
Total duration = 10 min at least | - | - |
Abbreviations: bpm Beats per minute, HIIT High-Intensity Interval Training, HR Heart Rate, HRmax Maximal heart rate, MCT Moderate Continuous Training, m/min Metres/minute, min Minute, q-RCT Quasi-Randomized Controlled Trial, RCT Randomized Controlled Trial, RM Repetition Maximum, VO2max Maximal oxygen uptake
Table 11.
Summary of prescription parameters for each exercise modality based on the prescription parameters used in the included studies
Type of intervention | Migraine diagnosis | Trials | Type of exercise | Distribution | Frequency | Duration (per session) | Intensity | Exercise testing | Grade of recommendation |
---|---|---|---|---|---|---|---|---|---|
Moderate intensity continuous aerobic training | Episodic or chronic migraine |
N = 12 RCTs (n = 6): Hanssen 2018 [49], Varkey 2011 [67], Hanssen 2017 [50], Oliveira 2017 [62], Oliveira 2019 [63], Ahmadi 2015 [41] Q-RCTs (n = 5): Darabaneanu 2011 [47], Luedtke 2020 [56], Varkey 2009 [66], Overath 2014 [64], Narin 2003 [61] Cohort (n = 1): Hagan 2021 [71] |
Supervised modalities: running, jogging, indoor cycling or cross-training Unsupervised modalities: nordic walking, slow running, outdoor cycling, swimming, cycling ergometer, brisk walking, dancing, other activities Supervised exercise (n = 9): Hanssen 2018 [49], Varkey 2011 [67], Hanssen 2017 [50], Oliveira 2017 [62], Oliveira 2019 [63], Darabaneanu 2011 [47], Varkey 2009 [66], Overath 2014 [64], Narin 2003 [61] Supervised and unsupervised exercise (n = 2): Luedtke 2020 [56], Narin 2003 [61] No information concerning supervised/unsupervised (n = 1): Ahmadi 2015 [41] |
Warm up from 5 to 15 min with walking, jogging, or easy cycling Main training performed from 20 to 30 min Cool down from 5 to 10 min with easy cycling, jogging, walking or stretching |
2–3 times/week for 5–12 weeks | Total duration of 30 to 50 min |
Warm up gradually increased from 11 to 13 Borg Main training performed between 13–16 Borg, 70% HRmax (± 5 bpm) or at the intensity corresponding to participant’s ventilatory threshold Cool down between 11–13 Borg |
Initial evaluation of individual anaerobic lactate-threshold, HRmax, VO2 max or ventilatory threshold (calculated with lactate blood test or respiratory gas exchange analysis) Monitoring during exercise with Borg scale, %HRmax and/or speed (m/min) |
B in favour of intervention |
Yoga | Episodic migraine |
N = 6 RCTs (6): Kumar 2020 [54], Kisan 2014 [52], Boroujeni 2015 [45], John 2007 [51], Mehta 2021 [58], Wells 2021 [68] |
Yoga: Full program under supervision; the first session or first month is supervised and the rest of the program is performed at home with audio-visual guidance if possible, or ensuring compliance with the routine with a telephone call every week or two months and/or with a diary checking compliance or self-reported yoga log maintained by the patient, and/or with the possibility of visiting professionals |
First part: Starting prayer, breathing, stretching and relaxation exercise (including Instant Relaxation Technique and Quick Relaxation Technique). Eye-related and backward bending exercise Second part: Asanas, savana, pavanmoktasanas, pranayama or pre-pranayama, neti exercise, standing-sitting and lying out screw position, kriya (Jalaneti followed by Kapalbhanti), sukshma vyayama, surya namaskar Final part: Shavasana or relaxation |
3–7 times/week for 6–12 weeks | Total duration of 60–75 min | - | - | B in favour of intervention |
Exercise and lifestyle recommendations | Episodic and chronic migraine |
N = 5 RCTs = 2 Bond 2018 [44], Lemstra 2002 [55] Cohort = 3 Seok 2006 [72], Wodeamanuel 2016 [73] Gaul 2011 [70] |
Home-based exercise, stretching, light weightlifting training, endurance training (mainly using sport gym equipment), or any modality of daily aerobic exercise that raise the heart rate | - | 3–7 times/week for 6 weeks to more than 6 months | Total duration of 20–60 min | Main training performed at a moderate to submaximal intensity | - | B in favour of intervention |
Relaxation techniques | Episodic and chronic migraine | RCTs (n = 3): Varkey 2011 [67], Meyer 2016 [59], Minen 2020 [60] | - | 6 relaxation exercises based on breathing and stress-management techniques, from 5 to 20 min of duration each exercise, or Progressive Muscle Relaxation including 16 muscle exercises or Smartphone app with Progressive Muscle Relaxation program | 1–6 times/week for 6–12 weeks | Total duration of 15 min to 120 min | - | - | C in favour of intervention |
High-intensity aerobic interval training | Episodic migraine |
N = 3 RCTs = 3 Hanssen 2017 [50] Hanssen 2018 [49] Matin 2022 [57] |
Running on a treadmill Bicycle Supervised |
Warm-up = 400 m easy running on a treadmill and 2 skipping exercises or 10 min cycling Main training = High-intensity interval running on a treadmill or bicycle Cool down = 400 m easy running on a treadmill and stretching exercises or 5 min cycling |
2–3 times/week for 8–12 weeks |
Main training = 10–40 min High intensity – moderate intensity intervals (min) = 4–3 High-moderate intensity intervals were repeated 4 times |
High intensity: Progression from Borg 11 to 18 or from 60% VO2 max to 80% in 8 weeks Maximum high-intensity reached 90%-95% HR Max Maximum active rest period intensity reached: 70% HRmax |
-Individual anaerobic lactate-threshold -HRmax -VO2 max (supervised) -Borg |
C in favour of intervention |
Low-intensity aerobic exercise | Episodic migraine |
N = 2 RCT (1): Santiago 2014 [65] Q-RCT (1): Köseglu 2003 [53] |
Home active exercise or fast walk outdoors, not supervised |
Warm-up exercises for 10 min Main training performed for 20–40 min Resting period performed for 10 min |
3 times/week for 6–12 weeks | Total duration of 40 min | Main training performed at 60% HRmax | HR | C in favour of intervention |
Exercise and relaxation techniques | Episodic and chronic migraine |
RCT (n = 2): Dittrich 2008 [48] Mehta 2021 [58] Q-RCTs (n = 1) Butt 2022 [46] |
Relaxation exercise and stationary cycling, or gymnastics with music, aerobic and strength training, or stretching, isometric exercise and walking Not reported if supervised or not |
Warm up = 5–10 min Main training = 30 min of moderate aerobic exercise or 15–25 min of aerobic training and 10–20 of strength training Or self-stretching of neck muscles (30 s hold 3 repetitions), neck isometric exercise (5 s hold, 10 repetitions) and 30 min walking Progressive muscle relaxation = 15 min Cool down or stretching = 5 min |
2–3 times/week for 6–12 weeks | Total duration of 45–60 min | - | - | C in favour of intervention |
Neck strength exercise | Episodic migraine | RCT (n = 1): Benatto 2002 [43] | Strength exercise for superficial and deep flexor and extensor craniocervical musculature with home exercise for craniocervical musculature and stretching |
First stage: deep muscle training, 2 sets of 10 repetitions for deep flexor and extensor musculature, for 6 weeks. Individually progressed in number of series, repetitions and endurance Second stage: deep and superficial muscle training for the next 2 weeks, including 3 sets of 15 repetitions for superficial flexor and extensor musculature |
1 day per week under supervision and 2 times/day everyday with home exercises for 8 weeks | Total duration of 20 min | - | - | C against the intervention |
Tai Chi | Episodic migraine |
N = 1 RCTs (n = 1): Xie 2022 [69] |
Modified 33-short form of Yang-style Tai Chi Chuan, (including the form “closing”) The protocol included both supervised and unsupervised exercise |
Warm-up with stretching for 10 min Main training of 45 min, with the first 5 weeks learning individual exercises of the Tai Chi exercise program The following 6–12 weeks participants perform the whole Tai-Chi exercise program, 3 times per session Cool-down with stretching for 5 min |
5 times/week for 12 weeks | Total duration of 60 min | - | - | C in favour of intervention |
Resistance exercise | Episodic migraine | RCTs (n = 1): Aslani [42] |
Resistance exercise with dumbbells, arm pull down, arm pull over, sit up, leg curl machine, and leg extension machine Not reported if supervised or not |
Warm up for 15 min with jogging, stretching, and weightlifting Main training performed from 30 to 45 min, 2–3 sets of 8–15 repetitions of arm pull down, arm pull over, sit up, leg extension and leg curl Cool down for 5 min with active cooling and stretching movements |
3 times/week for 8 weeks | Total duration of 30 to 45 min | Main training gradually performed from 45% RM to 75% RM | RM | C in favour of intervention |
Qi-Gong | Episodic migraine | Case series (n = 1): Elinoff 2019 [74] |
Supervised exercise Ju Fu (Gentle Wind) method |
First face-to-face history of Qi-Gong explanation and exercise sequence = Ju Fu (Gentle Wind) -Qigong exercise DVD duplicating the content of the first and subsequent lessons for home practice Two subsequent face-to-face sessions to reinforce training and add complexity and length to the Kiko sequence |
Daily home practice, for 3 months Two subsequent face-to-face sessions every 30 days |
Total duration of 10 min at least | - | - | D in favour of intervention |
Abbreviations: bpm Beats per minute, HR Heart rate, HRmax Maximal heart rate, m/min Meters/minute, min Minutes, q-RCT Quasi–Randomized Clinical Trial, RCT Randomized Controlled Trial, RM Repetition Maximum, VO2max Maximal oxygen uptake
Limitations and future directions
The purpose of this clinical practice guideline is to describe in depth the scientific evidence on exercise prescription for patients with migraine in order to facilitate decision making by physical therapists and other health and exercise professionals. Analysis of the information incorporated herein shows that in the last decade there has been an increase in the number of studies on the effectiveness of exercise in patients with migraine. Most of the research we included presented positive effects; however, there are several limitations in these studies that should be considered when interpreting the results and considering the future direction of studies in this area.
One of the most important limitations of the analyzed and included evidence is related to the comparisons used in the studies: the control groups employed a wide variety of interventions, including waiting lists, placebo, and pharmacological treatments. This limitation is fundamentally derived from ethical requirements, given that pharmacotherapy is established as the first line of treatment, and this situation substantially complicates determining the real magnitude of the effect of the various exercise modalities on migraine.
In relation to the above, it should also be considered that it is not possible to establish a real placebo comparison for treatments in which behavior modification is promoted, as in the case of exercise.
Another limitation is that most of the studies based on exercise and migraine evaluated immediate response, in short and intermediate terms, and only a few studies measured long-term effects. We believe that it is necessary to design studies that assess long-term effects to identify whether the effect is dependent on the duration of the exercise intervention or whether the effect is maintained for a long time after the intervention. At least a one year follow up would be recommended [24]. It would also be necessary to perform analyses that identify the level of adherence to the interventions related to exercise.
When using exercise with migraine patients the question arises as to whether it is appropriate to exercise with very intense pain. There is no evidence about the effects of the exercise while the patient is under severe pain, however we consider we must be cautious when prescribing exercise. If the patient has very intense pain, very frequently and/or the exercise is a clear trigger factor, the most appropriate recommendation would be to prescribe a gradual and individualized exposure to exercise.
There remain some unknowns about the effect of exercise on the patient with migraine that need to be addressed in future research. Studies do not currently compare which exercise modality is most effective in reducing the frequency, duration, and intensity of migraine pain, and it would be interesting to identify whether integrating various exercise modalities (e.g., aerobic exercise and strength training) is more effective than using each modality individually.
The evidence currently available does not clarify whether the improvement of physical variables through exercise has an impact on the frequency, duration, and intensity of migraine. It would be necessary to perform studies that introduce as covariates the level of physical activity, strength, or the improvement of range of motion or cardiovascular capacity and determine whether these variables are associated with the improvement of clinical variables.
Finally, we consider it opportune that subsequent studies take into account the psychological status of the patients to better select the most appropriate exercise modality, due to the growing number of studies that point out the impact that kinesiophobia has on patients with migraine [94, 104, 105]. Considering this factor, prescribing an exercise modality, such as gradual exposure to exercise, may be the most appropriate selection for this patient profile.
Conclusions
This clinical practice guideline has followed a rigorous process of quality assessment of the scientific evidence related to the effectiveness of exercise on migraine. Our analysis indicates that aerobic exercise, moderate intensity aerobic exercise, yoga, and lifestyle recommendations that include exercise present a grade B of recommendation for reducing the frequency, duration, and intensity of pain and improving the quality of life in patients with migraine.
The exercise modalities that are effective and have a grade C of recommendation are relaxation techniques, interval training at high intensity, continuous low-intensity aerobic exercise, Tai Chi, and resistance training (strength training). Finally, grade D of recommendation was given to Qi-Gong.
Supplementary Information
Acknowledgements
We would like to thank the collaboration of the Professional College of Physiotherapists of Community of Madrid for granting the funding for this project.
Authors’ contributions
RLT, ARV, and APA conceived and designed the clinical practice guideline; JFM, ISR, BRRR, and CDCL elaborated and performed the search strategy and inclusion of the articles; JFM and ISR evaluated the methodological quality and risk of bias of the included studies; RLT, ARV, JFM, ISR, BRRR, and CDCL developed and structured the operational definitions of each intervention, methodological quality, risk of bias, level of evidence, recommendation grade, prescription parameters, and intervention summary, and prepared the figures, tables, and the documentation for the consensus group; SLL, NRS, FAFM, IEG, JFC, LMG, JPM, APA constituted the consensus group and performed the validation of the different operational definitions of each intervention, methodological quality, risk of bias, level of evidence, recommendation grade, prescription parameters, and intervention summary; RLT, ARV, JFM, ISR, BRRR, CDCL, and APA have drafted the manuscript, and RLT, ARV, JFM, ISR, BRRR, CDCL, SLL, NRS, FAFM, IEG, JFC, LMG, JPM, APA have revised it. The author(s) read and approved the final manuscript.
Funding
The Professional College of Physiotherapists of the Community of Madrid provided funding and support for this clinical practice guideline. This institution did not take part in the development of the recommendations.
Declarations
Ethics approval and consent to participate
The present article is a clinical practice guideline that does not require an ethical approval.
Consent for publication
The present article has not included participants due to its design.
Competing interests
The authors declare that they have no competing interests.
Footnotes
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Vos T, Abajobir AA, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390:1211–1259. doi: 10.1016/S0140-6736(17)32154-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Stovner LJ, Nichols E, Steiner TJ, et al. Global, regional, and national burden of migraine and tension-type headache, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2018;17:954–976. doi: 10.1016/S1474-4422(18)30322-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Buse DC, Fanning KM, Reed ML, et al. Life with migraine: effects on relationships, career, and finances from the Chronic Migraine Epidemiology and Outcomes (CaMEO) study. Headache J Head Face Pain. 2019;59:1286–1299. doi: 10.1111/head.13613. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Berg J, Stovner LJ. Cost of migraine and other headaches in Europe. Eur J Neurol. 2005;12:59–62. doi: 10.1111/j.1468-1331.2005.01192.x. [DOI] [PubMed] [Google Scholar]
- 5.Cameron C, Kelly S, Hsieh S-C, et al. Triptans in the acute treatment of migraine: a systematic review and network meta-analysis. Headache J Head Face Pain. 2015;55:221–235. doi: 10.1111/head.12601. [DOI] [PubMed] [Google Scholar]
- 6.Evers S, Áfra J, Frese A, et al. EFNS guideline on the drug treatment of migraine - revised report of an EFNS task force. Eur J Neurol. 2009;16:968–981. doi: 10.1111/j.1468-1331.2009.02748.x. [DOI] [PubMed] [Google Scholar]
- 7.Lattanzi S, Brigo F, Trinka E, et al. Erenumab for preventive treatment of migraine: a systematic review and meta-analysis of efficacy and safety. Drugs. 2019;79:417–431. doi: 10.1007/s40265-019-01069-1. [DOI] [PubMed] [Google Scholar]
- 8.Herd CP, Tomlinson CL, Rick C, et al (2019) Cochrane systematic review and meta-analysis of botulinum toxin for the prevention of migraine. BMJ Open 9:e027953. 10.1136/BMJOPEN-2018-027953 [DOI] [PMC free article] [PubMed]
- 9.Yang CP, Liang CS, Chang CM, et al (2021) Comparison of new pharmacologic agents with triptans for treatment of migraine: a systematic review and meta-analysis. JAMA Netw Ppen 4:e2128544. 10.1001/JAMANETWORKOPEN.2021.28544 [DOI] [PMC free article] [PubMed]
- 10.Bigal ME, Walter S, Rapoport AM. Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development. Headache. 2013;53:1230–1244. doi: 10.1111/HEAD.12179. [DOI] [PubMed] [Google Scholar]
- 11.Seng EK, Martin PR, Houle TT. Lifestyle factors and migraine. Lancet Neurol. 2022;21:911–921. doi: 10.1016/S1474-4422(22)00211-3. [DOI] [PubMed] [Google Scholar]
- 12.Seng EK, Gosnell I, Sutton L, Grinberg AS. Behavioral management of episodic migraine: maintaining a healthy consistent lifestyle. Curr Pain Headache Rep. 2022;26:247–252. doi: 10.1007/s11916-022-01023-z. [DOI] [PubMed] [Google Scholar]
- 13.Varangot-Reille C, Suso-Martí L, Romero-Palau M et al (2021) Effects of different therapeutic exercise modalities on migraine or tension-type headache: a systematic review and meta-analysis with a replicability analysis. J Pain 23:1099-1122. 10.1016/j.jpain.2021.12.003 [DOI] [PubMed]
- 14.Woldeamanuel YW, Oliveira ABD. What is the efficacy of aerobic exercise versus strength training in the treatment of migraine? A systematic review and network meta-analysis of clinical trials. J Headache Pain. 2022;23:134. doi: 10.1186/s10194-022-01503-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Reina-Varona Á, Rodríguez de Rivera-Romero B, Cabrera-López CD, et al (2022) Exercise interventions in migraine patients: a YouTube content analysis study based on grades of recommendation. PeerJ 10:e14150. 10.7717/PEERJ.14150/SUPP-4 [DOI] [PMC free article] [PubMed]
- 16.Demarquay G, Mawet J, Guégan-Massardier E, et al. Revised guidelines of the French headache society for the diagnosis and management of migraine in adults. Part 3: Non-pharmacological treatment. Rev Neurol (Paris) 2021;177:753–759. doi: 10.1016/J.NEUROL.2021.07.009. [DOI] [PubMed] [Google Scholar]
- 17.Schytz HW, Amin FM, Jensen RH, et al (2021) Reference programme: diagnosis and treatment of headache disorders and facial pain. Danish Headache Society, 3rd edition, 2020. J Headache Pain 22:22. 10.1186/S10194-021-01228-4 [DOI] [PMC free article] [PubMed]
- 18.American Headache Society (2019) The American Headache Society position statement on integrating new migraine treatments into clinical practice. Headache 59:1–1810.1111/HEAD.13456 [DOI] [PubMed]
- 19.Chen Y, Yang K, Marušić A, et al. A reporting tool for practice guidelines in health care: the RIGHT statement. Ann Intern Med. 2017;166:128–132. doi: 10.7326/M16-1565. [DOI] [PubMed] [Google Scholar]
- 20.Brouwers MC, Kerkvliet K, Spithoff K (2016) The AGREE Reporting Checklist: a tool to improve reporting of clinical practice guidelines. BMJ 352:i1152. 10.1136/bmj.i1152 [DOI] [PMC free article] [PubMed]
- 21.Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535–b2535. doi: 10.1136/bmj.b2535. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Stone PW. Popping the (PICO) question in research and evidence-based practice. Appl Nurs Res. 2002;15:197–198. doi: 10.1053/apnr.2002.34181. [DOI] [PubMed] [Google Scholar]
- 23.Olesen J (2018) Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 38:1–211. 10.1177/0333102417738202 [DOI] [PubMed]
- 24.Furlan AD, Pennick V, Bombardier C, van Tulder M (2009) 2009 updated method guidelines for systematic reviews in the Cochrane back review group. Spine (Phila Pa 1976) 34:1929–1941. 10.1097/BRS.0b013e3181b1c99f [DOI] [PubMed]
- 25.Barton CJ, Webster KE, Menz HB (2008) Evaluation of the scope and quality of systematic reviews on nonpharmacological conservative treatment for patellofemoral pain syndrome. J Orthop Sports Phys Ther 38:529–541. https://www.jospt.org/doi/10.2519/jospt.2008.2861 [DOI] [PubMed]
- 26.de Morton NA. The PEDro scale is a valid measure of the methodological quality of clinical trials: a demographic study. Aust J Physiother. 2009;55:129–133. doi: 10.1016/S0004-9514(09)70043-1. [DOI] [PubMed] [Google Scholar]
- 27.Wells G, Shea B, O’Connell D, et al (2014) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. In: Ottawa Hosp. https://www.ohri.ca//programs/clinical_epidemiology/oxford.asp
- 28.Kim J-S. Electrocochleography in cochlear implant users with residual acoustic hearing: a systematic review. Int J Environ Res Public Health. 2020;17:7043. doi: 10.3390/ijerph17197043. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Baethge C, Goldbeck-Wood S, Mertens S (2019) SANRA-a scale for the quality assessment of narrative review articles. Res Integr peer Rev 4:5. 10.1186/S41073-019-0064-8 [DOI] [PMC free article] [PubMed]
- 30.Whiting P, Savović J, Higgins JPT, et al. ROBIS: A new tool to assess risk of bias in systematic reviews was developed. J Clin Epidemiol. 2016;69:225–234. doi: 10.1016/j.jclinepi.2015.06.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Sterne JAC, Savović J, Page MJ, et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898. 10.1136/bmj.l4898 [DOI] [PubMed]
- 32.McHugh ML (2012) Interrater reliability: the kappa statistic. Biochem Medica 22:276–282. 10.11613/BM.2012.031 [PMC free article] [PubMed]
- 33.Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. BMJ. 2001;323:334–336. doi: 10.1136/bmj.323.7308.334. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Vernooij RWM, Alonso-Coello P, Brouwers M, Martínez García L (2017) Reporting items for updated clinical guidelines: Checklist for the Reporting of Updated Guidelines (CheckUp). PLOS Med 14:e1002207. 10.1371/JOURNAL.PMED.1002207 [DOI] [PMC free article] [PubMed]
- 35.Herranz-Gómez A, García-Pascual I, Montero-Iniesta P, et al (2021) Effectiveness of exercise and manual therapy as treatment for patients with migraine, tension-type headache or cervicogenic headache: An umbrella and mapping review with meta-meta-analysis. Appl Sci 11:6856 10.3390/APP11156856
- 36.Lemmens J, De Pauw J, Van Soom T, et al. The effect of aerobic exercise on the number of migraine days, duration and pain intensity in migraine: a systematic literature review and meta-analysis. J Headache Pain. 2019;20:16. doi: 10.1186/s10194-019-0961-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37.Long C, Ye J, Chen M, et al. Effectiveness of yoga therapy for migraine treatment: A meta-analysis of randomized controlled studies. Am J Emerg Med. 2022;58:95–99. doi: 10.1016/J.AJEM.2022.04.050. [DOI] [PubMed] [Google Scholar]
- 38.Luedtke K, Allers A, Schulte LH, May A. Efficacy of interventions used by physiotherapists for patients with headache and migraine—systematic review and meta-analysis. Cephalalgia. 2016;36:474–492. doi: 10.1177/0333102415597889. [DOI] [PubMed] [Google Scholar]
- 39.Wu Q, Liu P, Liao C, Tan L. Effectiveness of yoga therapy for migraine: A meta-analysis of randomized controlled studies. J Clin Neurosci. 2022;99:147–151. doi: 10.1016/j.jocn.2022.01.018. [DOI] [PubMed] [Google Scholar]
- 40.La Touche R, Fernández Pérez JJ, Proy Acosta A, et al. Is aerobic exercise helpful in patients with migraine? A systematic review and meta-analysis. Scand J Med Sci Sport. 2020;30:965–982. doi: 10.1111/sms.13625. [DOI] [PubMed] [Google Scholar]
- 41.Ahmadi Z. The effect of 8-week aerobic exercise on migraine headache indices and blood nitric oxide level in women with migraine. Sport Physiol. 2015;7:33–50. [Google Scholar]
- 42.Aslani PS, Hassanpour M, Razi O, Knechtle B (2021) Resistance training reduces pain indices and improves quality of life and body strength in women with migraine disorders. Sport Sci Health 18:433–443. 10.21203/RS.3.RS-573627/V1
- 43.Benatto MT, Florencio LL, Bragatto MM, et al. Neck-specific strengthening exercise compared with placebo sham ultrasound in patients with migraine: a randomized controlled trial. BMC Neurol. 2022;22:126. doi: 10.1186/s12883-022-02650-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Bond DS, Thomas JG, Lipton RB, et al. Behavioral weight loss intervention for migraine: a randomized controlled trial. Obesity. 2018;26:81–87. doi: 10.1002/oby.22069. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Boroujeni M, Marandi S, Esfarjani F, et al. Yoga intervention on blood NO in female migraineurs. Adv Biomed Res. 2015;4:259. doi: 10.4103/2277-9175.172995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46.Butt MN, Maryum M, Amjad I et al (2022) Effects of aerobic exercise and progressive muscle relaxation on migraine. J Pak Med Assoc 72:1153–1157. 10.47391/JPMA.0838 [DOI] [PubMed]
- 47.Darabaneanu S, Overath CH, Rubin D, et al. Aerobic exercise as a therapy option for migraine: A pilot study. Int J Sports Med. 2011;32:455–460. doi: 10.1055/s-0030-1269928. [DOI] [PubMed] [Google Scholar]
- 48.Dittrich SM, Günther V, Franz G, et al. Aerobic exercise with relaxation: Influence on pain and psychological well-being in female migraine patients. Clin J Sport Med. 2008;18:363–365. doi: 10.1097/JSM.0b013e31817efac9. [DOI] [PubMed] [Google Scholar]
- 49.Hanssen H, Minghetti A, Magon S, et al. Effects of different endurance exercise modalities on migraine days and cerebrovascular health in episodic migraineurs: A randomized controlled trial. Scand J Med Sci Sport. 2018;28:1103–1112. doi: 10.1111/sms.13023. [DOI] [PubMed] [Google Scholar]
- 50.Hanssen H, Minghetti A, Magon S, et al (2017) Superior effects of high-intensity interval training vs. moderate continuous training on arterial stiffness in episodic migraine: a randomized controlled trial. Front Physiol 8:1086. 10.3389/fphys.2017.01086 [DOI] [PMC free article] [PubMed]
- 51.John PJ, Sharma N, Sharma CM, Kankane A. Effectiveness of yoga therapy in the treatment of migraine without aura: a randomized controlled trial. Headache J Head Face Pain. 2007;47:654–661. doi: 10.1111/j.1526-4610.2007.00789.x. [DOI] [PubMed] [Google Scholar]
- 52.Kisan R, Sujan M, Adoor M et al (2014) Effect of Yoga on migraine: A comprehensive study using clinical profile and cardiac autonomic functions. Int J Yoga 7:126. [DOI] [PMC free article] [PubMed]
- 53.Köseoglu E, Akboyraz A, Soyuer A, Ersoy AÖ. Aerobic exercise and plasma beta endorphin levels in patients with migrainous headache without aura. Cephalalgia. 2003;23:972–976. doi: 10.1046/j.1468-2982.2003.00624.x. [DOI] [PubMed] [Google Scholar]
- 54.Kumar A, Bhatia R, Sharma G, et al. Effect of yoga as add-on therapy in migraine (CONTAIN): A randomized clinical trial. Neurology. 2020;94:e2203–e2212. doi: 10.1212/WNL.0000000000009473. [DOI] [PubMed] [Google Scholar]
- 55.Lemstra M, Stewart B, Olszynski WP. Effectiveness of multidisciplinary intervention in the treatment of migraine: a randomized clinical trial. Headache J Head Face Pain. 2002;42:845–854. doi: 10.1046/j.1526-4610.2002.02202.x. [DOI] [PubMed] [Google Scholar]
- 56.Luedtke K, Starke W, von Korn K, et al. Neck treatment compared to aerobic exercise in migraine: A preference-based clinical trial. Cephalalgia Reports. 2020;3:1–9. doi: 10.1177/2515816320930681. [DOI] [Google Scholar]
- 57.Matin H, Taghian F, Chitsaz A. Artificial intelligence analysis to explore synchronize exercise, cobalamin, and magnesium as new actors to therapeutic of migraine symptoms: a randomized, placebo-controlled trial. Neurol Sci. 2022;43:4413–4424. doi: 10.1007/s10072-021-05843-6. [DOI] [PubMed] [Google Scholar]
- 58.Mehta JN, Parikh S, Desai SD, et al. Study of additive effect of yoga and physical therapies to standard pharmacologic treatment in migraine. J Neurosci Rural Pract. 2021;12:060–066. doi: 10.1055/s-0040-1718842. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59.Meyer B, Keller A, Wöhlbier H-G, et al. Progressive muscle relaxation reduces migraine frequency and normalizes amplitudes of contingent negative variation (CNV) J Headache Pain. 2016;17:37. doi: 10.1186/s10194-016-0630-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60.Minen MT, Adhikari S, Padikkala J, et al. Smartphone-delivered progressive muscle relaxation for the treatment of migraine in primary care: a randomized controlled trial. Headache. 2020;60:2232–2246. doi: 10.1111/head.14010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Narin SO, Pinar L, Erbas D, et al. The effects of exercise and exercise-related changes in blood nitric oxide level on migraine headache. Clin Rehabil. 2003;17:624–630. doi: 10.1191/0269215503cr657oa. [DOI] [PubMed] [Google Scholar]
- 62.Oliveira AB, Bachi ALL, Ribeiro RT, et al. Exercise-induced change in plasma IL-12p70 is linked to migraine prevention and anxiolytic effects in treatment-naïve women: a randomized controlled trial. NeuroImmunoModulation. 2017;24:293–299. doi: 10.1159/000487141. [DOI] [PubMed] [Google Scholar]
- 63.Oliveira AB, Ribeiro RT, Mello MT, et al. Anandamide is related to clinical and cardiorespiratory benefits of aerobic exercise training in migraine patients: a randomized controlled clinical trial. Cannabis Cannabinoid Res. 2019;4:275–284. doi: 10.1089/can.2018.0057. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64.Overath CH, Darabaneanu S, Evers MC, et al (2014) Does an aerobic endurance programme have an influence on information processing in migraineurs? J Headache Pain 15:11. 10.1186/1129-2377-15-11 [DOI] [PMC free article] [PubMed]
- 65.Santiago MDS, de Carvalho D, S, Gabbai AA, , et al. Amitriptyline and aerobic exercise or amitriptyline alone in the treatment of chronic migraine: a randomized comparative study. Arq Neuropsiquiatr. 2014;72:851–855. doi: 10.1590/0004-282X20140148. [DOI] [PubMed] [Google Scholar]
- 66.Varkey E, Cider Å, Carlsson J, Linde M. A study to evaluate the feasibility of an aerobic exercise program in patients with migraine. Headache J Head Face Pain. 2009;49:563–570. doi: 10.1111/j.1526-4610.2008.01231.x. [DOI] [PubMed] [Google Scholar]
- 67.Varkey E, Cider Å, Carlsson J, Linde M. Exercise as migraine prophylaxis: A randomized study using relaxation and topiramate as controls. Cephalalgia. 2011;31:1428–1438. doi: 10.1177/0333102411419681. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 68.Wells RE, O’Connell N, Pierce CR, et al. Effectiveness of mindfulness meditation vs headache education for adults with migraine: a randomized clinical trial. JAMA Intern Med. 2021;181:317–328. doi: 10.1001/JAMAINTERNMED.2020.7090. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Xie YJ, Tian L, Hui SS-C et al (2022) Efficacy and feasibility of a 12-week Tai Chi training for the prophylaxis of episodic migraine in Hong Kong Chinese women: A randomized controlled trial. Front Public Heal 10:1000594. 10.3389/fpubh.2022.1000594 [DOI] [PMC free article] [PubMed]
- 70.Gaul C, van Doorn C, Webering N, et al. Clinical outcome of a headache-specific multidisciplinary treatment program and adherence to treatment recommendations in a tertiary headache center: an observational study. J Headache Pain. 2011;12:475–483. doi: 10.1007/s10194-011-0348-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 71.Hagan KK, Li W, Mostofsky E, et al. Prospective cohort study of routine exercise and headache outcomes among adults with episodic migraine. Headache J Head Face Pain. 2021;61:493–499. doi: 10.1111/head.14037. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 72.Seok JI, Cho HI, Chung C-S. From transformed migraine to episodic migraine: reversion factors. Headache J Head Face Pain. 2006;46:1186–1190. doi: 10.1111/j.1526-4610.2006.00509.x. [DOI] [PubMed] [Google Scholar]
- 73.Woldeamanuel YW, Cowan RP. The impact of regular lifestyle behavior in migraine: a prevalence case–referent study. J Neurol. 2016;263:669–676. doi: 10.1007/s00415-016-8031-5. [DOI] [PubMed] [Google Scholar]
- 74.Elinoff V, Lynn SJ, Ochiai H, Hallquist M. The efficacy of Kiko exercises on the prevention of migraine headaches: A pilot study. Am J Chin Med. 2009;37:459–470. doi: 10.1142/S0192415X09006977. [DOI] [PubMed] [Google Scholar]
- 75.Ahn AH. Why does increased exercise decrease migraine? Curr Pain Headache Rep. 2013;17:379. doi: 10.1007/s11916-013-0379-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 76.Amin FM, Aristeidou S, Baraldi C, et al. The association between migraine and physical exercise. J Headache Pain. 2018;19:83. doi: 10.1186/s10194-018-0902-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 77.Barber M, Pace A (2020) Exercise and Migraine Prevention: a Review of the Literature. Curr Pain Headache Rep 24:39. 10.1007/S11916-020-00868-6 [DOI] [PubMed]
- 78.Becker WJ, Sauro KM. Recent studies on stress management-related treatments for migraine. Headache J Head Face Pain. 2009;49:1387–1390. doi: 10.1111/j.1526-4610.2009.01476.x. [DOI] [PubMed] [Google Scholar]
- 79.Busch V, Gaul C. Sport bei Migräne. Der. Schmerz. 2008;22:137–147. doi: 10.1007/s00482-007-0586-8. [DOI] [PubMed] [Google Scholar]
- 80.Busch V, Gaul C. Exercise in migraine therapy—is there any evidence for efficacy? A critical review. Headache J Head Face Pain. 2008;48:890–899. doi: 10.1111/j.1526-4610.2007.01045.x. [DOI] [PubMed] [Google Scholar]
- 81.Daenen L, Varkey E, Kellmann M, Nijs J. Exercise, not to exercise, or how to exercise in patients with chronic pain? Applying science to practice. Clin J Pain. 2015;31:108–114. doi: 10.1097/AJP.0000000000000099. [DOI] [PubMed] [Google Scholar]
- 82.Hindiyeh NA, Krusz JC, Cowan RP. Does exercise make migraines worse and tension type headaches better? Curr Pain Headache Rep. 2013;17:380. doi: 10.1007/s11916-013-0380-5. [DOI] [PubMed] [Google Scholar]
- 83.Irby MB, Bond DS, Lipton RB, et al. Aerobic exercise for reducing migraine burden: mechanisms, markers, and models of change processes. Headache J Head Face Pain. 2016;56:357–369. doi: 10.1111/head.12738. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 84.Lippi G, Mattiuzzi C, Sanchis-Gomar F (2018) Physical exercise and migraine: for or against? Ann Transl Med 6:181. 10.21037/atm.2018.04.15 [DOI] [PMC free article] [PubMed]
- 85.Mauskop A. Nonmedication, alternative, and complementary treatments for migraine. Contin Lifelong Learn Neurol. 2012;18:796–806. doi: 10.1212/01.CON.0000418643.24408.40. [DOI] [PubMed] [Google Scholar]
- 86.Meyer B, Keller A, Müller B, et al. Progressive muskelrelaxation nach Jacobson bei der migräneprophylaxe. Der Schmerz. 2018;32:250–258. doi: 10.1007/s00482-018-0305-7. [DOI] [PubMed] [Google Scholar]
- 87.Guarín-Duque HA, Pablo-Navarro B, Bermúdez-Moreno G, et al. Aportaciones del ejercicio al mejoramiento de los síntomas de la migraña y el papel de Enfermería. Revisión bibliográfica Ocronos. 2021;4:164. [Google Scholar]
- 88.Patel PS, Minen MT. Complementary and integrative health treatments for migraine. J Neuro-Ophthalmology. 2019;39:360–369. doi: 10.1097/WNO.0000000000000841. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 89.Robblee J, Starling AJ. SEEDS for success: Lifestyle management in migraine. Cleve Clin J Med. 2019;86:741–749. doi: 10.3949/ccjm.86a.19009. [DOI] [PubMed] [Google Scholar]
- 90.Song T-J, Chu MK. Exercise in treatment of migraine including chronic migraine. Curr Pain Headache Rep. 2021;25:14. doi: 10.1007/s11916-020-00929-w. [DOI] [PubMed] [Google Scholar]
- 91.Tepper SJ. Nutraceutical and other modalities for the treatment of headache. Contin Lifelong Learn Neurol. 2015;21:1018–1031. doi: 10.1212/CON.0000000000000211. [DOI] [PubMed] [Google Scholar]
- 92.Wells RE, Beuthin J, Granetzke L. Complementary and integrative medicine for episodic migraine: an update of evidence from the last 3 years. Curr Pain Headache Rep. 2019;23:10. doi: 10.1007/s11916-019-0750-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 93.Agbetou M, Adoukonou T (2022) Lifestyle modifications for migraine management. Front Neurol 13:719467. 10.3389/FNEUR.2022.719467 [DOI] [PMC free article] [PubMed]
- 94.Martins IP, Gouveia RG, Parreira E. Kinesiophobia in migraine J pain. 2006;7:445–451. doi: 10.1016/J.JPAIN.2006.01.449. [DOI] [PubMed] [Google Scholar]
- 95.ACSM’s (2021) ACSMs Guidelines for Exercise Testing and Prescription, 11th ed. Wolters Kluwer
- 96.Lin PJ, Peppone LJ, Janelsins MC et al (2018) Yoga for the management of cancer treatment-related toxicities. Curr Oncol Rep 20:5. 10.1007/S11912-018-0657-2 [DOI] [PMC free article] [PubMed]
- 97.Lu YH, Rosner B, Chang G, Fishman LM. Twelve-minute daily yoga regimen reverses osteoporotic bone loss. Top Geriatr Rehabil. 2016;32:81–87. doi: 10.1097/TGR.0000000000000085. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 98.Thulasi A, Kumar V, Jagannathan A et al (2022) Development and validation of yoga program for patients with type 2 diabetes mellitus (T2DM). J Relig Health 61:1951–1965. 10.1007/S10943-019-00859-X [DOI] [PubMed]
- 99.Kabbouche MA, Gilman DK. Management of migraine in adolescents. Neuropsychiatr Dis Treat. 2008;4:535. doi: 10.2147/NDT.S495. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 100.Taylor JL, Holland DJ, Spathis JG et al (2019) Guidelines for the delivery and monitoring of high intensity interval training in clinical populations. Prog Cardiovasc Dis 62(2):140–146. 10.1016/j.pcad.2019.01.004 [DOI] [PubMed]
- 101.Alghwiri AA, Whitney SL (2012) Balance and falls. In: Geriatric Physical Therapy. Elsevier, pp 331–353
- 102.Sorace P, LaFontaine T. Resistance training muscle power: design programs that work! ACSMs Health Fit J. 2005;9:6–12. [Google Scholar]
- 103.National Center for Complementary and Integrative Health Tai Chi: what you need to know | NCCIH. https://www.nccih.nih.gov/health/tai-chi-what-you-need-to-know
- 104.Benatto MT, Bevilaqua-Grossi D, Carvalho GF, et al. Kinesiophobia is associated with migraine. Pain Med (United States) 2019;20:846–851. doi: 10.1093/PM/PNY206. [DOI] [PubMed] [Google Scholar]
- 105.Pinheiro CF, Bevilaqua-Grossi D, Florencio LL et al (2022) Is kinesiophobia related to fear of falling, dizziness disability, and migraine disability in patients with migraine? Physother Theory Pract 38:2727–2735. 10.1080/09593985.2021.1996496 [DOI] [PubMed]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.